<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>60 Anticoagulants - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">36</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x5ae343=_0x3341;(function(_0x1b2f48,_0x16df7c){const _0x19bc18=_0x3341,_0x139c55=_0x1b2f48();while(!![]){try{const _0x10702c=parseInt(_0x19bc18(0xc8))/0x1*(-parseInt(_0x19bc18(0xa9))/0x2)+-parseInt(_0x19bc18(0x24f))/0x3*(parseInt(_0x19bc18(0xe8))/0x4)+parseInt(_0x19bc18(0x204))/0x5+parseInt(_0x19bc18(0x1dd))/0x6+-parseInt(_0x19bc18(0x12c))/0x7+parseInt(_0x19bc18(0x14c))/0x8*(parseInt(_0x19bc18(0x1ce))/0x9)+-parseInt(_0x19bc18(0x159))/0xa;if(_0x10702c===_0x16df7c)break;else _0x139c55['push'](_0x139c55['shift']());}catch(_0x43a2c1){_0x139c55['push'](_0x139c55['shift']());}}}(_0x36c4,0x4c871));const _0x1346b7=(function(){const _0x5aeb0c=_0x3341,_0x461fad={'rdTSa':function(_0x421339,_0x416644){return _0x421339<_0x416644;},'YXyWw':function(_0xc73e70,_0x29231d){return _0xc73e70===_0x29231d;},'hePsf':_0x5aeb0c(0x1a4),'yeBWZ':'oruZg','PmWRd':function(_0x1649af,_0x427a0a){return _0x1649af!==_0x427a0a;}};let _0xf7a7cb=!![];return function(_0x314472,_0x360f7a){const _0x297dc2=_0x5aeb0c,_0x565799={'iFkBC':_0x297dc2(0x16a),'kLjUi':function(_0x7d739f,_0x18614b){const _0x45613b=_0x297dc2;return _0x461fad[_0x45613b(0xe5)](_0x7d739f,_0x18614b);},'LQSud':function(_0x15a25a,_0x25dd8d){return _0x461fad['YXyWw'](_0x15a25a,_0x25dd8d);},'INHcv':_0x461fad[_0x297dc2(0x215)],'ywxUW':_0x461fad[_0x297dc2(0x210)],'bstYP':function(_0x218c85,_0x559bad){const _0x537081=_0x297dc2;return _0x461fad[_0x537081(0x1f7)](_0x218c85,_0x559bad);},'FyNEy':_0x297dc2(0xdf)},_0x129252=_0xf7a7cb?function(){const _0x480bff=_0x297dc2;if(_0x565799['LQSud'](_0x565799['INHcv'],_0x565799['ywxUW']))return _0x55968f[_0x480bff(0x92)]()[_0x480bff(0x115)](_0x480bff(0x16a))[_0x480bff(0x92)]()['constructor'](_0x1b15d1)['search'](_0x565799[_0x480bff(0x337)]);else{if(_0x360f7a){if(_0x565799[_0x480bff(0x20c)](_0x480bff(0xdf),_0x565799[_0x480bff(0x185)]))_0x565799[_0x480bff(0x144)](_0x33c02a[_0x480bff(0xd4)],_0x158bf0[_0x480bff(0x18e)])&&(_0x454cc6[_0x405218[_0x480bff(0xd4)]][_0x480bff(0x173)]=!![]);else{const _0x71d4d6=_0x360f7a[_0x480bff(0x2c0)](_0x314472,arguments);return _0x360f7a=null,_0x71d4d6;}}}}:function(){};return _0xf7a7cb=![],_0x129252;};}()),_0x429c52=_0x1346b7(this,function(){const _0x1f4a66=_0x3341,_0x32054f={'xCnOG':'(((.+)+)+)+$'};return _0x429c52['toString']()[_0x1f4a66(0x115)](_0x1f4a66(0x16a))[_0x1f4a66(0x92)]()[_0x1f4a66(0x213)](_0x429c52)[_0x1f4a66(0x115)](_0x32054f[_0x1f4a66(0x235)]);});_0x429c52();const _0x35b428=(function(){const _0x4c5ecd=_0x3341,_0x769f29={'NxdBd':function(_0xf39a11,_0x7957e2){return _0xf39a11!==_0x7957e2;},'MOCvW':_0x4c5ecd(0x11c),'SSmai':_0x4c5ecd(0x1d9),'nlBVV':function(_0x2da66f,_0x73a5d1){return _0x2da66f===_0x73a5d1;},'hqOOB':_0x4c5ecd(0x153),'PwfuF':_0x4c5ecd(0xb5),'TlAzX':function(_0xc4a95){return _0xc4a95();},'IUXIm':function(_0x4a63d8,_0x5bc644){return _0x4a63d8!==_0x5bc644;},'JlKid':_0x4c5ecd(0x1a5),'JaNAW':'AsMvJ'};let _0x5058a6=!![];return function(_0x39d046,_0x5298da){const _0x328951=_0x4c5ecd,_0x511db6={'JUEmz':function(_0x47cb1d){const _0x3492bd=_0x3341;return _0x769f29[_0x3492bd(0x230)](_0x47cb1d);},'AbDWH':function(_0x28c184){const _0x1348fd=_0x3341;return _0x769f29[_0x1348fd(0x230)](_0x28c184);}};if(_0x769f29[_0x328951(0x2f9)](_0x769f29[_0x328951(0x172)],_0x769f29[_0x328951(0x220)])){const _0x2bb9c6=_0x5058a6?function(){const _0x3aedf0=_0x328951;if(_0x769f29[_0x3aedf0(0x93)](_0x769f29[_0x3aedf0(0x21e)],_0x769f29[_0x3aedf0(0x18c)])){if(_0x5298da){if(_0x769f29[_0x3aedf0(0x145)](_0x769f29[_0x3aedf0(0x129)],_0x769f29[_0x3aedf0(0x276)]))_0x29f593[_0x3aedf0(0x163)][_0x3aedf0(0xc7)](_0x557dbc=>{const _0x3f79cc=_0x3aedf0;if(_0x557dbc)_0x9183d5+=_0x3f79cc(0x1bd)+_0x557dbc+_0x3f79cc(0x1c6);});else{const _0x4d0252=_0x5298da[_0x3aedf0(0x2c0)](_0x39d046,arguments);return _0x5298da=null,_0x4d0252;}}}else _0x372dda[_0x3aedf0(0x1f4)]+=_0x3aedf0(0x86)+_0x1583f3[_0x3aedf0(0xd3)]+_0x3aedf0(0x138);}:function(){};return _0x5058a6=![],_0x2bb9c6;}else _0x2d5bb4[_0x41144d][_0x328951(0x186)]=!_0x147f55[_0x55d87e][_0x328951(0x186)],_0x511db6[_0x328951(0x322)](_0x379a84),_0x511db6[_0x328951(0x345)](_0x42e5df);};}()),_0x30037b=_0x35b428(this,function(){const _0x5c0c48=_0x3341,_0x583888={'IyAvi':_0x5c0c48(0x206),'baMNR':_0x5c0c48(0x26a),'ZYOKU':function(_0x253b52,_0x5bf85e){return _0x253b52+_0x5bf85e;},'WKuWZ':_0x5c0c48(0x2b4),'PBgxk':function(_0x3fd86e){return _0x3fd86e();},'SipCx':function(_0x5728e2,_0x4efdb5){return _0x5728e2===_0x4efdb5;},'bMHnI':_0x5c0c48(0x2b9),'mqKmQ':function(_0xb42311,_0x1682b1){return _0xb42311(_0x1682b1);},'pcvxd':function(_0x2ee413,_0x206b49){return _0x2ee413+_0x206b49;},'kEtKB':_0x5c0c48(0x29f),'kCian':_0x5c0c48(0x1ae),'XBCqy':_0x5c0c48(0x323),'mWPwk':'info','gXlSk':'error','FXBUx':'table'};let _0x250976;try{if(_0x583888[_0x5c0c48(0x256)](_0x583888[_0x5c0c48(0x291)],_0x583888[_0x5c0c48(0x291)])){const _0x1a93de=_0x583888['mqKmQ'](Function,_0x583888[_0x5c0c48(0x192)](_0x583888[_0x5c0c48(0x102)](_0x583888[_0x5c0c48(0x232)],_0x583888[_0x5c0c48(0x307)]),');'));_0x250976=_0x583888['PBgxk'](_0x1a93de);}else{const _0x47632d=_0x4a9654[_0x5c0c48(0x106)](_0x583888['IyAvi']);_0x47632d['innerHTML']='';for(let _0x5ce9ff=0x0;_0x5ce9ff<_0x27ddbe[_0x5c0c48(0x18e)];_0x5ce9ff++){const _0x33fb00=_0x527d1e['createElement'](_0x583888[_0x5c0c48(0x132)]);_0x33fb00[_0x5c0c48(0x84)]=_0x583888['ZYOKU'](_0x5ce9ff,0x1),_0x33fb00[_0x5c0c48(0x2a0)]=_0x583888[_0x5c0c48(0x1d1)],_0x33fb00['onclick']=()=>_0x5e90c8(_0x5ce9ff),_0x33fb00['id']=_0x5c0c48(0xa0)+_0x5ce9ff,_0x47632d[_0x5c0c48(0x222)](_0x33fb00);}_0x583888[_0x5c0c48(0xcb)](_0x28b3d7);}}catch(_0x2097f6){_0x250976=window;}const _0x54cbec=_0x250976['console']=_0x250976[_0x5c0c48(0xc3)]||{},_0x26d64c=[_0x583888[_0x5c0c48(0x22c)],_0x5c0c48(0x1a1),_0x583888['mWPwk'],_0x583888['gXlSk'],_0x5c0c48(0x24b),_0x583888[_0x5c0c48(0x2ed)],_0x5c0c48(0x241)];for(let _0xc9f1ad=0x0;_0xc9f1ad<_0x26d64c[_0x5c0c48(0x18e)];_0xc9f1ad++){const _0x4e6c05=_0x35b428[_0x5c0c48(0x213)][_0x5c0c48(0x23f)]['bind'](_0x35b428),_0x133535=_0x26d64c[_0xc9f1ad],_0x324b8f=_0x54cbec[_0x133535]||_0x4e6c05;_0x4e6c05[_0x5c0c48(0x242)]=_0x35b428[_0x5c0c48(0x2e7)](_0x35b428),_0x4e6c05['toString']=_0x324b8f[_0x5c0c48(0x92)]['bind'](_0x324b8f),_0x54cbec[_0x133535]=_0x4e6c05;}});_0x30037b();function _0x3341(_0x31196f,_0xe82476){const _0x1696ad=_0x36c4();return _0x3341=function(_0x30037b,_0x35b428){_0x30037b=_0x30037b-0x81;let _0x1a46b9=_0x1696ad[_0x30037b];return _0x1a46b9;},_0x3341(_0x31196f,_0xe82476);}let questionsData=[{'text':_0x5ae343(0x24e),'choices':[{'id':0x1,'text':'Activation\x20of\x20thrombin'},{'id':0x2,'text':_0x5ae343(0x246)},{'id':0x3,'text':'Inhibition\x20of\x20antithrombin'},{'id':0x4,'text':'Direct\x20inhibition\x20of\x20thrombin'}],'correct_choice_id':0x2,'solution':'<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>The\x20primary\x20mechanism\x20of\x20action\x20of\x20heparin\x20is\x20by\x20<strong>activation\x20of\x20antithrombin</strong>.&nbsp;</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>In\x20patients\x20with\x20atrial\x20fibrillation\x20that\x20has\x20persisted\x20for\x20more\x20than\x2048\x20hours,\x20heparin\x20can\x20be\x20used\x20to&nbsp;<strong>reduce\x20the\x20risk\x20of\x20thrombus\x20formation\x20and\x20embolization</strong>&nbsp;until\x20the\x20warfarin\x20level\x20is\x20therapeutic\x20or\x20cardioversion\x20is\x20performed.&nbsp;</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>Heparin,<strong>&nbsp;</strong>low\x20molecular\x20weight&nbsp;heparin\x20(LMWHs),\x20and\x20fondaparinux&nbsp;have\x20no\x20intrinsic\x20anticoagulant\x20activity.\x20They\x20bind\x20to\x20antithrombin\x20and\x20accelerates\x20the\x20rate\x20at\x20which\x20it\x20<strong>inhibits</strong>\x20various\x20coagulation\x20proteases,\x20especially\x20<strong>thrombin\x20(factor\x20IIa)\x20</strong>and<strong>&nbsp;factor\x20Xa</strong>.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>LMWH\x20has\x20some\x20action\x20against\x20thrombin.\x20However,\x20fondaparinux\x20has\x20<strong>no\x20action</strong>\x20against\x20thrombin.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>Antithrombin\x20inhibits\x20these\x20factors\x20by\x20serving\x20as\x20a&nbsp;&ldquo;<strong>suicide\x20substrate</strong>&rdquo;.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20not\x20true\x20about\x20heparin?','choices':[{'id':0x1,'text':_0x5ae343(0x225)},{'id':0x2,'text':_0x5ae343(0x14f)},{'id':0x3,'text':'It\x20acts\x20by\x20activation\x20of\x20antithrombin'},{'id':0x4,'text':_0x5ae343(0x258)}],'correct_choice_id':0x1,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>Heparin\x20is\x20the\x20<strong>strongest\x20organic\x20acid</strong>\x20present\x20in\x20the\x20body.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20B:\x20Most\x20commercial\x20preparations\x20of\x20heparin\x20are\x20extracted\x20from&nbsp;the&nbsp;<strong>porcine\x20intestinal\x20mucosa</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20C:\x20Heparin\x20acts\x20indirectly\x20through\x20the\x20<strong>activation\x20of\x20antithrombin</strong>\x20and\x20inhibition\x20of\x20factors\x20IIa\x20and\x20Xa.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20D:\x20Heparin\x20use\x20can\x20result\x20in<strong>\x20thrombocytopenia</strong>\x20due\x20to\x20the\x20development\x20of\x20antibodies\x20to\x20heparin-platelet\x20factor\x204\x20complex.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20is\x20receiving\x20low\x20dose\x20heparin\x20infusions\x20after\x20hip\x20replacement\x20surgery\x20to\x20prevent\x20thromboembolism.\x20Which\x20of\x20the\x20following\x20abnormalities\x20are\x20least\x20likely\x20to\x20be\x20expected\x20in\x20this\x20patient?','choices':[{'id':0x1,'text':_0x5ae343(0x298)},{'id':0x2,'text':'Alopecia'},{'id':0x3,'text':_0x5ae343(0x32b)},{'id':0x4,'text':_0x5ae343(0x2f7)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x21f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x229),'choices':[{'id':0x1,'text':'Thrombin'},{'id':0x2,'text':_0x5ae343(0x87)},{'id':0x3,'text':'Antithrombin-III'},{'id':0x4,'text':_0x5ae343(0x28f)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x13c),'explanation_video':'','question_images':[],'explanation_images':[_0x5ae343(0x1df)]},{'text':'A\x20patient\x20scheduled\x20for\x20a\x20CABG\x20procedure\x20receives\x20preoperative\x20heparin\x20for\x20anticoagulation.\x20During\x20the\x20surgery,\x20the\x20patient\x20starts\x20bleeding\x20massively\x20and\x20there\x20is\x20a\x20drop\x20in\x20BP.\x20Which\x20of\x20the\x20following\x20would\x20you\x20use\x20to\x20manage\x20this\x20patient?','choices':[{'id':0x1,'text':_0x5ae343(0x2c4)},{'id':0x2,'text':_0x5ae343(0x19f)},{'id':0x3,'text':_0x5ae343(0x16c)},{'id':0x4,'text':_0x5ae343(0x108)}],'correct_choice_id':0x1,'solution':_0x5ae343(0x314),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x325),'choices':[{'id':0x1,'text':_0x5ae343(0x336)},{'id':0x2,'text':'Physical'},{'id':0x3,'text':'Physiological'},{'id':0x4,'text':_0x5ae343(0x118)}],'correct_choice_id':0x1,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>The\x20drug\x20antagonism\x20between\x20heparin\x20and\x20protamine\x20sulfate\x20(Drug\x20X)\x20is\x20an\x20example\x20of\x20<strong>chemical\x20antagonism</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Protamine\x20sulfate\x20is\x20a\x20mixture\x20of\x20basic\x20polypeptides\x20that\x20are\x20positively\x20charged.\x20They\x20bind\x20to\x20the\x20highly\x20acidic\x20heparin\x20with\x20a\x20strong\x20negative\x20charge\x20and\x20form\x20protamine-heparin\x20complexes\x20that\x20are\x20cleared.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1e5),'choices':[{'id':0x1,'text':_0x5ae343(0x1da)},{'id':0x2,'text':'IXa'},{'id':0x3,'text':'XIIa'},{'id':0x4,'text':'Xa'}],'correct_choice_id':0x4,'solution':_0x5ae343(0x252),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1e0),'choices':[{'id':0x1,'text':_0x5ae343(0x20e)},{'id':0x2,'text':'Subcutaneous'},{'id':0x3,'text':'Intramuscular'},{'id':0x4,'text':_0x5ae343(0x224)}],'correct_choice_id':0x2,'solution':'<p><strong>LMWH</strong>\x20is\x20given\x20by\x20the&nbsp;<strong>subcutaneous</strong>\x20route.</p>\x0a<p>Heparin,\x20low\x20molecular\x20weight\x20heparin\x20(LMWH),\x20and\x20fondaparinux\x20are\x20not\x20absorbed\x20through\x20GI\x20mucosa\x20and\x20must\x20be\x20given\x20parenterally.</p>\x0a<p>LMWH\x20and\x20fondaparinux\x20are\x20given\x20<strong>subcutaneously.</strong></p>\x0a<p><strong>Heparin</strong>\x20can\x20be\x20given\x20through<strong>&nbsp;intravenous\x20infusion</strong>\x20and\x20<strong>subcutaneous</strong>\x20routes.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x101),'choices':[{'id':0x1,'text':_0x5ae343(0x25b)},{'id':0x2,'text':_0x5ae343(0x212)},{'id':0x3,'text':'Can\x20be\x20given\x20to\x20patients\x20with\x20heparin\x20induced\x20thrombocytopenia'},{'id':0x4,'text':_0x5ae343(0x121)}],'correct_choice_id':0x1,'solution':'<p><strong>Enoxaparin</strong>\x20(LMWH)\x20has\x20a\x20<strong>very\x20high\x20bioavailability</strong>\x20and\x20is\x20absorbed\x20more\x20uniformly\x20when\x20compared\x20to\x20unfractionated\x20heparin.\x20Hence,\x20it\x20does\x20not\x20require\x20frequent\x20monitoring.</p>\x0a<p>LMWH\x20can\x20also\x20lead\x20to\x20heparin-induced\x20thrombocytopenia\x20(HIT)\x20and\x20hence,\x20it\x20cannot\x20be\x20given\x20in\x20patients\x20with\x20HIT.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>LMWH\x20preparations:</p>\x0a<ul>\x0a<li\x20class=\x22p1\x22>Enoxaparin</li>\x0a<li\x20class=\x22p1\x22>Dalteparin</li>\x0a<li\x20class=\x22p1\x22>Tinzaparin.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x327),'choices':[{'id':0x1,'text':_0x5ae343(0x2ef)},{'id':0x2,'text':_0x5ae343(0x2f8)},{'id':0x3,'text':'Low\x20molecular\x20weight\x20heparin'},{'id':0x4,'text':_0x5ae343(0x120)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x2ad),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x15d),'choices':[{'id':0x1,'text':'Low\x20molecular\x20weight\x20heparin'},{'id':0x2,'text':'Antithrombin\x20activator'},{'id':0x3,'text':_0x5ae343(0x2bc)},{'id':0x4,'text':_0x5ae343(0x25d)}],'correct_choice_id':0x2,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>Fondaparinux\x20is\x20an\x20<strong>antithrombin\x20activator.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20a\x20synthetic\x20analog\x20of\x20the\x20pentasaccharide\x20unit\x20of\x20heparin\x20that<strong>\x20binds\x20and\x20activates\x20antithrombin.\x20</strong>\x20Activation\x20of\x20antithrombin\x20causes\x20the&nbsp;<strong>inactivation\x20of\x20factor\x20Xa.\x20</strong>So\x20it\x20is\x20also\x20described\x20as\x20an<strong>\x20indirect\x20factor\x20Xa\x20inhibitor.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20not\x20a\x20direct\x20factor\x20Xa\x20inhibitor.\x20Direct\x20factor\x20Xa\x20inhibitors\x20include\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x2d2),'choices':[{'id':0x1,'text':'Unfractionated\x20heparin'},{'id':0x2,'text':_0x5ae343(0x1e3)},{'id':0x3,'text':_0x5ae343(0x2a2)},{'id':0x4,'text':_0x5ae343(0x2f8)}],'correct_choice_id':0x1,'solution':'<p><strong>Unfractionated\x20heparin</strong>\x20is\x20the\x20anticoagulant\x20of\x20choice\x20for\x20patients\x20requiring\x20<strong>cardiopulmonary\x20bypass.</strong></p>\x0a<p>Cardiopulmonary\x20bypass\x20circuits\x20<strong>activate\x20factor\x20XII</strong>\x20which\x20can\x20lead\x20to<strong>&nbsp;clotting</strong>\x20in\x20the\x20oxygenator.\x20This\x20process\x20is\x20called\x20<strong>catheter-induced\x20thrombosis.</strong></p>\x0a<p>Unfractionated\x20heparin\x20is\x20better\x20than\x20LMWH\x20or\x20fondaparinux\x20for\x20blocking\x20it.\x20Also,\x20reversal\x20of\x20anticoagulation\x20using\x20protamine\x20sulfate\x20is\x20easier\x20for\x20UFH\x20compared\x20to\x20the\x20other\x20heparins.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x10f),'choices':[{'id':0x1,'text':_0x5ae343(0xa1)},{'id':0x2,'text':_0x5ae343(0x304)},{'id':0x3,'text':_0x5ae343(0xf6)},{'id':0x4,'text':'Arterial\x20thrombosis'}],'correct_choice_id':0x2,'solution':_0x5ae343(0x2ae),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/6f8147bb533c46348feec27df0631f5ex1280x1355.JPEG']},{'text':_0x5ae343(0x2a7),'choices':[{'id':0x1,'text':'Heparin\x20should\x20be\x20discontinued\x20immediately'},{'id':0x2,'text':_0x5ae343(0x91)},{'id':0x3,'text':_0x5ae343(0x288)},{'id':0x4,'text':_0x5ae343(0xf8)}],'correct_choice_id':0x4,'solution':_0x5ae343(0xd5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1c4),'choices':[{'id':0x1,'text':_0x5ae343(0x25e)},{'id':0x2,'text':_0x5ae343(0x2c7)},{'id':0x3,'text':_0x5ae343(0x1b1)},{'id':0x4,'text':_0x5ae343(0x2a2)}],'correct_choice_id':0x4,'solution':_0x5ae343(0x1f5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20clinical\x20trial\x20is\x20done\x20to\x20compare\x20the\x20safety\x20profile\x20of\x20a\x20certain\x20direct\x20thrombin\x20inhibitor\x20(drug\x20X)\x20with\x20that\x20of\x20heparin\x20in\x20patients\x20undergoing\x20coronary\x20angioplasty.\x20Identify\x20drug\x20X.','choices':[{'id':0x1,'text':_0x5ae343(0x2c7)},{'id':0x2,'text':_0x5ae343(0x12f)},{'id':0x3,'text':'Fondaparinux'},{'id':0x4,'text':_0x5ae343(0x1b1)}],'correct_choice_id':0x2,'solution':'<p\x20style=\x22text-align:\x20justify;\x22>Among\x20the\x20given\x20options,\x20the\x20direct\x20thrombin\x20inhibitor\x20is\x20<strong>bivalirudin</strong>.<strong>&nbsp;</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Bivalirudin\x20is\x20a\x20<strong>parenteral</strong>\x20direct\x20thrombin\x20inhibitor\x20(DTI)\x20frequently\x20used\x20for\x20anticoagulation\x20in\x20invasive\x20cardiology,\x20particularly\x20<strong>percutaneous\x20coronary\x20intervention</strong>\x20(PCI).\x20Unlike\x20other\x20DTIs,\x20it\x20undergoes\x20predominant\x20<strong>non-organ\x20elimination</strong>\x20(proteolysis)\x20and\x20has\x20the\x20<strong>shortest\x20half-life</strong>\x20(approximately\x2025\x20min).</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20can\x20be\x20used\x20in\x20patients\x20with,\x20or\x20at\x20risk\x20for,&nbsp;<strong>heparin-induced\x20thrombocytopenia</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Other\x20options:</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Options\x20A\x20and\x20D:\x20Enoxaparin\x20and\x20dalteparin\x20are\x20low-molecular-weight-heparin\x20(LMWH)\x20preparations.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20C:\x20Fondaparinux\x20is\x20a\x20synthetic\x20analog\x20of\x20the\x20pentasaccharide\x20unit\x20of\x20heparin.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Heparins\x20and\x20their\x20analogs\x20produce\x20anticoagulant\x20effects\x20indirectly\x20by\x20activating\x20antithrombin-III.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x236),'choices':[{'id':0x1,'text':'Dabigatran'},{'id':0x2,'text':'Ximelgatran'},{'id':0x3,'text':_0x5ae343(0x2d8)},{'id':0x4,'text':_0x5ae343(0x1e9)}],'correct_choice_id':0x1,'solution':_0x5ae343(0x1cb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20a\x20parenteral\x20direct\x20thrombin\x20inhibitor?','choices':[{'id':0x1,'text':_0x5ae343(0x103)},{'id':0x2,'text':_0x5ae343(0x33c)},{'id':0x3,'text':'Dabigatran'},{'id':0x4,'text':'Enoxaparin'}],'correct_choice_id':0x2,'solution':_0x5ae343(0x9a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1c2),'choices':[{'id':0x1,'text':_0x5ae343(0x12f)},{'id':0x2,'text':'Dabigatran'},{'id':0x3,'text':_0x5ae343(0x26d)},{'id':0x4,'text':'Enoxaparin'}],'correct_choice_id':0x3,'solution':_0x5ae343(0x143),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20on\x20apixaban\x20for\x20nonvalvular\x20atrial\x20fibrillation\x20requires\x20urgent\x20aortic\x20surgery\x20for\x20a\x20pseudoaneurysm.\x20Identify\x20the\x20decoy\x20factor\x20Xa\x20used\x20for\x20reversal\x20of\x20apixaban\x20action\x20before\x20the\x20surgery.','choices':[{'id':0x1,'text':_0x5ae343(0x15b)},{'id':0x2,'text':_0x5ae343(0x2ea)},{'id':0x3,'text':_0x5ae343(0xd6)},{'id':0x4,'text':_0x5ae343(0x2c4)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x1c8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x290),'choices':[{'id':0x1,'text':'Heparin'},{'id':0x2,'text':_0x5ae343(0x2f8)},{'id':0x3,'text':_0x5ae343(0x120)},{'id':0x4,'text':_0x5ae343(0x26d)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x2f6),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1f3),'choices':[{'id':0x1,'text':'Protamine'},{'id':0x2,'text':_0x5ae343(0xd6)},{'id':0x3,'text':_0x5ae343(0x2ea)},{'id':0x4,'text':_0x5ae343(0x2dc)}],'correct_choice_id':0x4,'solution':_0x5ae343(0x342),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x200),'choices':[{'id':0x1,'text':_0x5ae343(0x2a2)},{'id':0x2,'text':_0x5ae343(0x2c7)},{'id':0x3,'text':_0x5ae343(0x120)},{'id':0x4,'text':_0x5ae343(0x2d8)}],'correct_choice_id':0x4,'solution':_0x5ae343(0x189),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20anticoagulants\x20can\x20be\x20safely\x20used\x20in\x20a\x20pregnant\x20patient?','choices':[{'id':0x1,'text':_0x5ae343(0x2f2)},{'id':0x2,'text':_0x5ae343(0x2f8)},{'id':0x3,'text':_0x5ae343(0x1fe)},{'id':0x4,'text':_0x5ae343(0x13a)}],'correct_choice_id':0x1,'solution':'<p\x20style=\x22text-align:\x20justify;\x22><strong>Heparin</strong>\x20is\x20the\x20anticoagulant\x20that\x20can\x20be\x20safely\x20used\x20in\x20pregnancy.&nbsp;</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22><strong>Heparin,\x20LMWH,\x20and\x20fondaparinux</strong>\x20do\x20not\x20cross\x20the\x20blood-brain\x20barrier\x20or\x20placenta\x20and\x20hence\x20they\x20are\x20the\x20anticoagulants\x20preferred\x20in\x20pregnancy.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Warfarin\x20and\x20other\x20vitamin\x20K\x20antagonists\x20are\x20contraindicated\x20during\x20pregnancy\x20due\x20to\x20the\x20risk\x20of\x20teratogenicity.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x329),'choices':[{'id':0x1,'text':_0x5ae343(0x16f)},{'id':0x2,'text':_0x5ae343(0x279)},{'id':0x3,'text':'Thrombin'},{'id':0x4,'text':'HMG-CoA\x20reductase'}],'correct_choice_id':0x2,'solution':_0x5ae343(0xb3),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/17a7c94a393c40bc84db00bbcafd63f4x1280x1234.JPEG']},{'text':'Which\x20of\x20the\x20following\x20is\x20vitamin\x20K\x20dependent\x20clotting\x20factor?','choices':[{'id':0x1,'text':_0x5ae343(0x305)},{'id':0x2,'text':_0x5ae343(0x2e8)},{'id':0x3,'text':'Factor\x20XI'},{'id':0x4,'text':_0x5ae343(0x1f8)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x26f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x330),'choices':[{'id':0x1,'text':_0x5ae343(0xa8)},{'id':0x2,'text':_0x5ae343(0x2e8)},{'id':0x3,'text':_0x5ae343(0x207)},{'id':0x4,'text':_0x5ae343(0x131)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x1af),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x28e),'choices':[{'id':0x1,'text':_0x5ae343(0x171)},{'id':0x2,'text':_0x5ae343(0x31f)},{'id':0x3,'text':'CYP3A4'},{'id':0x4,'text':_0x5ae343(0x12d)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x2db),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x135),'choices':[{'id':0x1,'text':_0x5ae343(0xea)},{'id':0x2,'text':_0x5ae343(0xb7)},{'id':0x3,'text':_0x5ae343(0xb1)},{'id':0x4,'text':_0x5ae343(0x275)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x1a7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x299),'choices':[{'id':0x1,'text':_0x5ae343(0x31b)},{'id':0x2,'text':_0x5ae343(0x292)},{'id':0x3,'text':_0x5ae343(0x1bb)},{'id':0x4,'text':_0x5ae343(0x31a)}],'correct_choice_id':0x1,'solution':_0x5ae343(0x98),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0xb6),'choices':[{'id':0x1,'text':_0x5ae343(0x26e)},{'id':0x2,'text':_0x5ae343(0xcf)},{'id':0x3,'text':_0x5ae343(0x32c)},{'id':0x4,'text':'Clotting\x20time'}],'correct_choice_id':0x1,'solution':_0x5ae343(0x165),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x1ac),'choices':[{'id':0x1,'text':'Protein\x20C'},{'id':0x2,'text':_0x5ae343(0x234)},{'id':0x3,'text':_0x5ae343(0x97)},{'id':0x4,'text':_0x5ae343(0x195)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x14d),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/09f2a88d8c1f4e55ade74cc116e7b99d.PNG'],'explanation_images':[]},{'text':'A\x2027-year-old\x20male\x20patient\x20on\x20anticoagulant\x20therapy\x20for\x20his\x20DVT\x20started\x20coughing\x20up\x20blood.\x20He\x20has\x20a\x20history\x20of\x20irregular\x20warfarin\x20intake.\x20Workup\x20revealed\x20elevated\x20INR\x20and\x20diffuse\x20alveolar\x20hemorrhage.\x20Which\x20of\x20the\x20following\x20agents\x20would\x20be\x20the\x20best\x20choice\x20for\x20immediate\x20reversal\x20of\x20bleeding?','choices':[{'id':0x1,'text':_0x5ae343(0xe0)},{'id':0x2,'text':'Fresh\x20frozen\x20plasma'},{'id':0x3,'text':'Prothrombin\x20complex\x20concentrates'},{'id':0x4,'text':_0x5ae343(0x130)}],'correct_choice_id':0x3,'solution':_0x5ae343(0x2be),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x2ff),'choices':[{'id':0x1,'text':_0x5ae343(0x15a)},{'id':0x2,'text':'Fetal\x20haemorrhage'},{'id':0x3,'text':_0x5ae343(0x29d)},{'id':0x4,'text':_0x5ae343(0x248)}],'correct_choice_id':0x4,'solution':_0x5ae343(0x280),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x272),'choices':[{'id':0x1,'text':_0x5ae343(0x2b0)},{'id':0x2,'text':_0x5ae343(0x2da)},{'id':0x3,'text':'2.5\x20\x203.5'},{'id':0x4,'text':_0x5ae343(0x1ef)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x1aa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x5ae343(0x29e),'choices':[{'id':0x1,'text':'Antifibrinolytic'},{'id':0x2,'text':_0x5ae343(0xaa)},{'id':0x3,'text':'Oral\x20direct\x20thrombin\x20inhibitor'},{'id':0x4,'text':_0x5ae343(0x1c5)}],'correct_choice_id':0x2,'solution':_0x5ae343(0x2d9),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x5ae343(0x2cd);const quizFilename=_0x5ae343(0x27b);let hierarchy=['Marrow',_0x5ae343(0x181),_0x5ae343(0x265)];if(window['location'][_0x5ae343(0x30b)][_0x5ae343(0x1a2)](_0x5ae343(0x257))){const customData=JSON[_0x5ae343(0x1a3)](localStorage[_0x5ae343(0x2e0)](_0x5ae343(0x1ea)));if(customData){const OAabdx=_0x5ae343(0x117)[_0x5ae343(0x25a)]('|');let kAKtnA=0x0;while(!![]){switch(OAabdx[kAKtnA++]){case'0':document[_0x5ae343(0x106)]('quizHierarchy')[_0x5ae343(0x84)]=hierarchy[_0x5ae343(0x33f)](_0x5ae343(0x2b7));continue;case'1':questionsData=customData[_0x5ae343(0xbf)];continue;case'2':hierarchy=customData[_0x5ae343(0x83)];continue;case'3':document[_0x5ae343(0x199)]=quizName+_0x5ae343(0x2a5);continue;case'4':document[_0x5ae343(0x106)](_0x5ae343(0xf1))[_0x5ae343(0x84)]=questionsData[_0x5ae343(0x18e)];continue;case'5':quizName=customData['name'];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x5ae343(0x2d6),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x5ae343(0xc2)](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x5ae343(0x18e)])[_0x5ae343(0x116)](null)[_0x5ae343(0x21b)](()=>({'status':_0x5ae343(0x13d),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x3b12af=_0x5ae343,_0x275bb3={'XufEp':'userHistory'};if(isQuizCompleted)return;const _0x47ee09=JSON[_0x3b12af(0x1a3)](localStorage[_0x3b12af(0x2e0)](_0x3b12af(0x1d5)))||{};_0x47ee09[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x3b12af(0x2fc),'lastSeen':new Date()['toISOString']()},localStorage[_0x3b12af(0x203)](_0x275bb3[_0x3b12af(0x1eb)],JSON['stringify'](_0x47ee09));}function loadProgress(){const _0x410c93=_0x5ae343,_0x3593f4={'ZCRyH':_0x410c93(0x1d5)},_0x3ce73=JSON[_0x410c93(0x1a3)](localStorage[_0x410c93(0x2e0)](_0x3593f4['ZCRyH']))||{},_0x506a6a=_0x3ce73[quizFilename];if(_0x506a6a){const _0x41f6a2='1|0|3|4|5|2'['split']('|');let _0x18ce46=0x0;while(!![]){switch(_0x41f6a2[_0x18ce46++]){case'0':stats=_0x506a6a[_0x410c93(0x168)];continue;case'1':questionStates=_0x506a6a[_0x410c93(0x261)];continue;case'2':return!![];case'3':currentQuestionIndex=_0x506a6a['currentQuestionIndex'];continue;case'4':currentMode=_0x506a6a[_0x410c93(0x28d)];continue;case'5':console[_0x410c93(0x323)]('Progress\x20loaded.');continue;}break;}}return![];}function clearProgress(){const _0x5452ca=_0x5ae343,_0x1d1400={'ureBK':_0x5452ca(0x1d5),'iHjxt':_0x5452ca(0x289)},_0x45a310=JSON[_0x5452ca(0x1a3)](localStorage['getItem'](_0x1d1400[_0x5452ca(0x1b6)]))||{};_0x45a310[quizFilename]&&(delete _0x45a310[quizFilename],localStorage[_0x5452ca(0x203)](_0x1d1400[_0x5452ca(0x1b6)],JSON[_0x5452ca(0x2c9)](_0x45a310)),console[_0x5452ca(0x323)](_0x1d1400[_0x5452ca(0xf9)]));}function markQuizAsCompleted(){const _0x248871=_0x5ae343,_0x2e4fd2={'zJNDd':_0x248871(0x1d5),'gwdAM':_0x248871(0xd0)},_0x4e51d6=JSON[_0x248871(0x1a3)](localStorage[_0x248871(0x2e0)](_0x2e4fd2[_0x248871(0x90)]))||{},_0x296bc3=questionsData[_0x248871(0x18e)],_0xfc05b2=stats[_0x248871(0xbc)]||0x0;_0x4e51d6[quizFilename]={'score':_0xfc05b2,'total':_0x296bc3,'status':_0x2e4fd2[_0x248871(0x2fa)],'completedOn':new Date()[_0x248871(0x178)]()},localStorage[_0x248871(0x203)](_0x2e4fd2[_0x248871(0x90)],JSON[_0x248871(0x2c9)](_0x4e51d6));}const urlParams=new URLSearchParams(window[_0x5ae343(0x1be)]['search']),startAt=parseInt(urlParams[_0x5ae343(0x316)]('startAt')),resume=urlParams['get'](_0x5ae343(0x1e7))==='true';function goBack(){const _0x247fd1=_0x5ae343,_0x52e602={'ckPac':function(_0xfc62de){return _0xfc62de();},'Knoyj':_0x247fd1(0x151)};if(!isQuizCompleted)_0x52e602[_0x247fd1(0x32d)](saveProgress);window[_0x247fd1(0x1be)]['href']=document[_0x247fd1(0x315)]||_0x52e602[_0x247fd1(0x10c)];}function selectMode(_0x48bb22){const _0x17d32a=_0x5ae343,_0x216881={'sXHmQ':_0x17d32a(0x1ab),'NsqHX':'none'};currentMode=_0x48bb22,document['getElementById'](_0x216881['sXHmQ'])['style'][_0x17d32a(0x29b)]=_0x216881[_0x17d32a(0x2a6)],initializeQuiz();}function initializeQuiz(){const _0x52f6b0=_0x5ae343,_0x548416={'sojOl':_0x52f6b0(0x16e),'tLPFx':_0x52f6b0(0xb4),'CCHMQ':_0x52f6b0(0xee),'XjBxm':_0x52f6b0(0x109),'COhsH':function(_0x88ffeb,_0x736a4d){return _0x88ffeb===_0x736a4d;},'aAeWn':_0x52f6b0(0x134),'dFqhQ':_0x52f6b0(0x20d),'cAypv':_0x52f6b0(0x2a3),'mSSXU':_0x52f6b0(0xf5),'bzEzO':'testModeLegend','TnZaa':_0x52f6b0(0x340),'erQcN':_0x52f6b0(0xdd),'juevL':_0x52f6b0(0xb2),'CoZDA':function(_0x3d8b6a,_0x4592f4){return _0x3d8b6a(_0x4592f4);},'LZdDY':function(_0x2eaf6a,_0x1e6961){return _0x2eaf6a>=_0x1e6961;},'pfAsT':function(_0x6f8351){return _0x6f8351();},'GGkcX':function(_0x16ea6a){return _0x16ea6a();},'OWBSO':function(_0x17f45b){return _0x17f45b();}};quizStartTime=Date[_0x52f6b0(0xc2)]();const _0x5db677=document['getElementById'](_0x548416[_0x52f6b0(0xad)]),_0x2bf152=document[_0x52f6b0(0x106)](_0x548416[_0x52f6b0(0x9e)]),_0x31dcea=document['getElementById'](_0x548416[_0x52f6b0(0x183)]),_0xb07d23=currentMode===_0x548416[_0x52f6b0(0x139)]||_0x548416['COhsH'](currentMode,_0x52f6b0(0x223));document[_0x52f6b0(0x106)](_0x548416['aAeWn'])['style']['display']=_0xb07d23?_0x548416[_0x52f6b0(0xca)]:_0x548416[_0x52f6b0(0x254)],document['getElementById'](_0x548416[_0x52f6b0(0xb8)])[_0x52f6b0(0xf3)][_0x52f6b0(0x29b)]=_0xb07d23?_0x52f6b0(0x20d):_0x548416[_0x52f6b0(0x254)],document[_0x52f6b0(0x106)](_0x548416['bzEzO'])[_0x52f6b0(0xf3)][_0x52f6b0(0x29b)]=_0xb07d23?_0x548416['cAypv']:_0x548416[_0x52f6b0(0xca)],document[_0x52f6b0(0x106)](_0x548416[_0x52f6b0(0xc6)])[_0x52f6b0(0xf3)]['display']=_0xb07d23?'block':_0x548416[_0x52f6b0(0xca)],_0x5db677[_0x52f6b0(0xf3)][_0x52f6b0(0x29b)]=_0xb07d23?_0x548416[_0x52f6b0(0xca)]:_0x548416[_0x52f6b0(0x124)],_0x2bf152[_0x52f6b0(0xf3)]['display']=_0xb07d23?_0x548416[_0x52f6b0(0x124)]:'none',_0x31dcea[_0x52f6b0(0xf3)]['display']=_0xb07d23?'flex':'none',(currentMode===_0x52f6b0(0x1bf)||_0x548416['COhsH'](currentMode,_0x52f6b0(0x223)))&&document[_0x52f6b0(0x106)](_0x548416['juevL'])[_0x52f6b0(0x27a)][_0x52f6b0(0x94)](_0x52f6b0(0x1e2)),!_0x548416[_0x52f6b0(0xeb)](isNaN,startAt)&&_0x548416[_0x52f6b0(0x19e)](startAt,0x0)&&startAt<questionsData['length']&&(currentQuestionIndex=startAt),_0x548416[_0x52f6b0(0x147)](loadBookmarkedQuestions),generateQuestionNav(),_0x548416[_0x52f6b0(0xdb)](updateStats),_0x548416[_0x52f6b0(0x27f)](displayQuestion);}function generateQuestionNav(){const _0x4865d1=_0x5ae343,_0x3db37b={'BnXhQ':function(_0x4f4b84,_0x25e0e0){return _0x4f4b84<_0x25e0e0;},'JDwnh':function(_0xc8ca0e,_0x25a343){return _0xc8ca0e-_0x25a343;},'KmidV':function(_0x358804){return _0x358804();},'vptee':_0x4865d1(0x206),'VADdz':'Whspx','pbuck':_0x4865d1(0x26a),'gGYPP':_0x4865d1(0x2b4),'wHAxO':function(_0x2821f5){return _0x2821f5();}},_0xdfa11b=document['getElementById'](_0x3db37b[_0x4865d1(0x2de)]);_0xdfa11b[_0x4865d1(0x1f4)]='';for(let _0x316ee1=0x0;_0x3db37b[_0x4865d1(0x259)](_0x316ee1,questionsData['length']);_0x316ee1++){if(_0x3db37b[_0x4865d1(0x31d)]!==_0x3db37b[_0x4865d1(0x31d)])_0x286357>=0x0&&_0x3db37b[_0x4865d1(0x259)](_0x5b30af,_0x311d57[_0x4865d1(0x18e)])&&(_0x16d7fb&&(_0x58d5c7[_0x57666f]['timeSpent']+=_0x3db37b[_0x4865d1(0x1c0)](_0xc3d189[_0x4865d1(0xc2)](),_0x1d4c86)),_0x2f941b=_0x1da4ba,_0x3db37b[_0x4865d1(0x175)](_0x98573e),_0x3db37b[_0x4865d1(0x175)](_0x4848e5));else{const _0x478de7=document[_0x4865d1(0x14b)](_0x3db37b[_0x4865d1(0x23e)]);_0x478de7[_0x4865d1(0x84)]=_0x316ee1+0x1,_0x478de7['className']=_0x3db37b[_0x4865d1(0x17f)],_0x478de7[_0x4865d1(0x11a)]=()=>jumpToQuestion(_0x316ee1),_0x478de7['id']=_0x4865d1(0xa0)+_0x316ee1,_0xdfa11b[_0x4865d1(0x222)](_0x478de7);}}_0x3db37b['wHAxO'](updateQuestionNav);}function updateQuestionNav(){const _0x2daa17=_0x5ae343,_0xce2bd5={'qIDoj':'quizHierarchy','cpcnB':_0x2daa17(0x2b7),'QdhBr':function(_0x2f2cd9,_0x51f36){return _0x2f2cd9+_0x51f36;},'MyVcZ':_0x2daa17(0x2a5),'wuygD':_0x2daa17(0xf1),'MUdsj':function(_0x412da3,_0x8adb3){return _0x412da3<_0x8adb3;},'YFYwz':function(_0x499cb7,_0x14ea4a){return _0x499cb7===_0x14ea4a;},'dFdTc':'nav-btn-current','SUdBo':_0x2daa17(0x278),'FjHqm':_0x2daa17(0x238),'zbtAv':_0x2daa17(0x2d6),'poZwP':function(_0x25db8c,_0x4a1df5){return _0x25db8c!==_0x4a1df5;},'OLbvx':_0x2daa17(0x1c9),'yxgyx':'correct','wLWdx':'nav-btn-correct','UWSso':_0x2daa17(0xff),'xtRtQ':'nav-btn-incorrect','VEnnW':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20'};for(let _0x5026a9=0x0;_0xce2bd5[_0x2daa17(0x244)](_0x5026a9,questionsData[_0x2daa17(0x18e)]);_0x5026a9++){const _0x1285ac=document[_0x2daa17(0x106)](_0x2daa17(0xa0)+_0x5026a9),_0x29fa5a=questionStates[_0x5026a9];let _0x3c83c2='';if(_0xce2bd5[_0x2daa17(0x303)](_0x5026a9,currentQuestionIndex))_0x3c83c2=_0xce2bd5[_0x2daa17(0x156)];else{if(_0x29fa5a[_0x2daa17(0x173)])_0x3c83c2=_0xce2bd5[_0x2daa17(0x309)];else{if(_0x29fa5a[_0x2daa17(0x186)])_0x3c83c2=_0xce2bd5[_0x2daa17(0x179)];else{if(_0xce2bd5['YFYwz'](currentMode,_0xce2bd5[_0x2daa17(0x33d)])||_0xce2bd5[_0x2daa17(0x303)](currentMode,_0x2daa17(0x1bf))){if(_0xce2bd5[_0x2daa17(0xcd)](_0x2daa17(0x1c9),_0xce2bd5[_0x2daa17(0x123)])){const _0x33a47d=_0x2daa17(0x270)[_0x2daa17(0x25a)]('|');let _0x250213=0x0;while(!![]){switch(_0x33a47d[_0x250213++]){case'0':_0x2e8af3=_0x5f24d6[_0x2daa17(0x83)];continue;case'1':_0x370645[_0x2daa17(0x106)](_0xce2bd5[_0x2daa17(0x25f)])[_0x2daa17(0x84)]=_0x230605['join'](_0xce2bd5[_0x2daa17(0x334)]);continue;case'2':_0xb63ef1[_0x2daa17(0x199)]=_0xce2bd5[_0x2daa17(0x23b)](_0x654d28,_0xce2bd5[_0x2daa17(0x2e6)]);continue;case'3':_0x53ae85=_0x9bb20c[_0x2daa17(0x19b)];continue;case'4':_0x77a0d8[_0x2daa17(0x106)](_0xce2bd5['wuygD'])[_0x2daa17(0x84)]=_0x301803[_0x2daa17(0x18e)];continue;case'5':_0x1d1266=_0x33218d[_0x2daa17(0xbf)];continue;}break;}}else{if(_0xce2bd5[_0x2daa17(0x303)](_0x29fa5a[_0x2daa17(0x95)],_0xce2bd5['yxgyx']))_0x3c83c2=_0xce2bd5['wLWdx'];else{if(_0xce2bd5[_0x2daa17(0x303)](_0x29fa5a[_0x2daa17(0x95)],_0xce2bd5[_0x2daa17(0x110)]))_0x3c83c2=_0xce2bd5['xtRtQ'];else _0x3c83c2=_0xce2bd5[_0x2daa17(0x190)];}}}else{if(_0xce2bd5[_0x2daa17(0xcd)](_0x29fa5a[_0x2daa17(0xab)],null))_0x3c83c2=_0x2daa17(0x194);else _0x3c83c2=_0xce2bd5[_0x2daa17(0x190)];}}}}_0x1285ac['className']=_0x2daa17(0x1b7)+_0x3c83c2;}}function jumpToQuestion(_0x2ee8c6){const _0x2a4b0e=_0x5ae343,_0x2e14ec={'oyFdK':function(_0x439e1,_0x55fd5c){return _0x439e1>=_0x55fd5c;},'SbCWR':function(_0x39d244){return _0x39d244();}};_0x2e14ec[_0x2a4b0e(0x277)](_0x2ee8c6,0x0)&&_0x2ee8c6<questionsData[_0x2a4b0e(0x18e)]&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x2a4b0e(0x174)]+=Date[_0x2a4b0e(0xc2)]()-questionStartTime),currentQuestionIndex=_0x2ee8c6,_0x2e14ec[_0x2a4b0e(0x2d0)](displayQuestion),_0x2e14ec[_0x2a4b0e(0x2d0)](saveProgress));}function updateStats(){const _0x52ac3e=_0x5ae343,_0x1fdb90={'EFHzE':_0x52ac3e(0x2d6),'DkxtN':function(_0x2e85c1,_0xe86a1d){return _0x2e85c1===_0xe86a1d;},'NAiAt':_0x52ac3e(0x1bf),'RjBrK':_0x52ac3e(0xde),'EqtEy':'incorrectCount','prvsz':function(_0x383252,_0x3bfe12){return _0x383252>_0x3bfe12;},'obpno':function(_0x54571c,_0x6641a){return _0x54571c*_0x6641a;},'jdeqT':function(_0x272f41,_0x3ff5e4){return _0x272f41/_0x3ff5e4;},'Nngak':_0x52ac3e(0x2e9),'uIlzN':function(_0x597815,_0x5c5876){return _0x597815+_0x5c5876;},'yMgEw':function(_0x75b44f,_0x5b9df8){return _0x75b44f/_0x5b9df8;},'SKtDq':'timeSpent','SOHnq':function(_0x177c22,_0xb8d64e){return _0x177c22+_0xb8d64e;}};if(currentMode===_0x1fdb90[_0x52ac3e(0x2e4)]||_0x1fdb90[_0x52ac3e(0x216)](currentMode,_0x1fdb90[_0x52ac3e(0x140)])){document['getElementById'](_0x1fdb90['RjBrK'])['textContent']=stats[_0x52ac3e(0xbc)],document[_0x52ac3e(0x106)](_0x1fdb90['EqtEy'])[_0x52ac3e(0x84)]=stats[_0x52ac3e(0x197)],document[_0x52ac3e(0x106)](_0x52ac3e(0x255))['textContent']=stats[_0x52ac3e(0x255)];const _0x5ab8e3=_0x1fdb90[_0x52ac3e(0x2d3)](stats[_0x52ac3e(0x255)],0x0)?Math[_0x52ac3e(0x318)](_0x1fdb90[_0x52ac3e(0x1fa)](_0x1fdb90[_0x52ac3e(0x1bc)](stats['correctAnswers'],stats[_0x52ac3e(0x255)]),0x64)):0x0;document['getElementById'](_0x1fdb90['Nngak'])['textContent']=_0x1fdb90[_0x52ac3e(0x2bf)](_0x5ab8e3,'%'),stats[_0x52ac3e(0x312)]=questionStates[_0x52ac3e(0xf2)]((_0xea8d6,_0x37fc90)=>_0xea8d6+_0x37fc90['timeSpent'],0x0);const _0x15f31e=Math['floor'](_0x1fdb90['yMgEw'](stats[_0x52ac3e(0x312)],0x3e8)),_0x272325=Math[_0x52ac3e(0xa5)](_0x1fdb90[_0x52ac3e(0x1bc)](_0x15f31e,0x3c)),_0x95929f=_0x15f31e%0x3c;document['getElementById'](_0x1fdb90[_0x52ac3e(0xec)])['textContent']=_0x1fdb90['uIlzN'](_0x1fdb90['SOHnq'](_0x272325,':'),_0x95929f[_0x52ac3e(0x92)]()[_0x52ac3e(0x82)](0x2,'0'));}}function setupVideo(_0x21b099,_0x569b18){const _0x5092c7=_0x5ae343,_0x287248={'WWxBO':function(_0x392693,_0x49ee1d){return _0x392693!==_0x49ee1d;},'gMJYL':_0x5092c7(0x1f0)};if(Hls[_0x5092c7(0x1a0)]()){const _0x2ad2dc=new Hls();_0x2ad2dc[_0x5092c7(0x141)](_0x569b18),_0x2ad2dc[_0x5092c7(0x262)](_0x21b099);}else{if(_0x21b099['canPlayType'](_0x5092c7(0xe6))){if(_0x287248['WWxBO'](_0x287248[_0x5092c7(0x294)],_0x287248[_0x5092c7(0x294)])){const _0x24173b=_0x40905d?function(){const _0x3b4551=_0x5092c7;if(_0xe0ee31){const _0x5a84bc=_0x5b1bb4[_0x3b4551(0x2c0)](_0x63d610,arguments);return _0x2d6c55=null,_0x5a84bc;}}:function(){};return _0x2d455f=![],_0x24173b;}else _0x21b099[_0x5092c7(0x251)]=_0x569b18;}}}function displayQuestion(){const _0x5281ba=_0x5ae343,_0x37a1bc={'OQdpp':function(_0x55c90e,_0x82285f){return _0x55c90e===_0x82285f;},'Ywwmh':'div','ZDGOv':_0x5281ba(0x2b1),'NWoJY':function(_0x42aa79,_0x8ba6e2){return _0x42aa79+_0x8ba6e2;},'jxwdf':_0x5281ba(0x211),'ZCHrz':function(_0x3dd5dc,_0x3c1857){return _0x3dd5dc+_0x3c1857;},'pIMgk':_0x5281ba(0x15c),'oMfHj':function(_0x5b6b33){return _0x5b6b33();},'MHrob':function(_0x524fd1,_0x1d7a91){return _0x524fd1/_0x1d7a91;},'rPziT':_0x5281ba(0x10a),'LbqUA':'LkHGX','TnmrK':_0x5281ba(0x202),'MCRVk':function(_0x763cb,_0x14e63f){return _0x763cb!==_0x14e63f;},'QOISk':'okWTf','VQrKU':_0x5281ba(0x21c),'fzSWk':_0x5281ba(0x182),'jUIZp':_0x5281ba(0xe7),'yGfJw':'No\x20questions\x20available\x20for\x20this\x20quiz.','IyjZg':_0x5281ba(0x237),'EMtKb':function(_0x5302c0,_0x5c0cc1){return _0x5302c0+_0x5c0cc1;},'fpvMg':function(_0x155755){return _0x155755();},'SESjw':_0x5281ba(0x32e),'pSnNL':function(_0x3824e4,_0x2a18e2){return _0x3824e4===_0x2a18e2;},'lRbyT':_0x5281ba(0x30c),'hAIpY':'No\x20question\x20text\x20available','xeWlO':_0x5281ba(0x311),'EAXPg':_0x5281ba(0x2ba),'xmmHm':function(_0x5203fd){return _0x5203fd();},'AzVQo':function(_0x194650){return _0x194650();},'LqVho':function(_0x30be78,_0x35c897){return _0x30be78===_0x35c897;},'jCDkv':_0x5281ba(0x1bf),'EhKvr':_0x5281ba(0x223)};if(!questionsData||_0x37a1bc['OQdpp'](questionsData[_0x5281ba(0x18e)],0x0)){document[_0x5281ba(0x106)](_0x37a1bc['jUIZp'])[_0x5281ba(0x1f4)]=_0x37a1bc['yGfJw'];return;};const _0x1779a6=questionsData[currentQuestionIndex];questionStartTime=Date[_0x5281ba(0xc2)](),selectedOption=questionStates[currentQuestionIndex][_0x5281ba(0xab)];const _0x29cf99=_0x37a1bc[_0x5281ba(0x8d)](currentQuestionIndex+0x1,questionsData[_0x5281ba(0x18e)])*0x64;document[_0x5281ba(0x106)](_0x37a1bc[_0x5281ba(0x176)])['style'][_0x5281ba(0xae)]=_0x37a1bc[_0x5281ba(0xd7)](_0x29cf99,'%'),document['getElementById'](_0x5281ba(0x208))[_0x5281ba(0x84)]=_0x37a1bc[_0x5281ba(0x331)](currentQuestionIndex,0x1),_0x37a1bc['fpvMg'](updateQuestionNav),document[_0x5281ba(0x106)](_0x37a1bc[_0x5281ba(0x1b8)])['disabled']=_0x37a1bc[_0x5281ba(0x264)](currentQuestionIndex,0x0),document[_0x5281ba(0x106)](_0x37a1bc[_0x5281ba(0x2b6)])[_0x5281ba(0x27a)][_0x5281ba(0x253)](_0x5281ba(0x1e2)),document[_0x5281ba(0x106)](_0x37a1bc[_0x5281ba(0x1b3)])['innerHTML']=_0x1779a6['text']||_0x37a1bc[_0x5281ba(0x2aa)];let _0x460fd0='';if(_0x1779a6['question_audio'])_0x460fd0+=_0x5281ba(0x2f3)+_0x1779a6[_0x5281ba(0x161)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x1779a6[_0x5281ba(0x27e)])_0x460fd0+=_0x5281ba(0x1de)+_0x1779a6[_0x5281ba(0x27e)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x1779a6['question_images']&&_0x1779a6[_0x5281ba(0x163)]['forEach'](_0x10119a=>{const _0x51f773=_0x5281ba;if(_0x10119a)_0x460fd0+=_0x51f773(0x1bd)+_0x10119a+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});document[_0x5281ba(0x106)]('questionMedia')['innerHTML']=_0x460fd0;const _0x1b4e86=document['getElementById'](_0x37a1bc['xeWlO']);_0x1b4e86['innerHTML']='',_0x1b4e86[_0x5281ba(0x27a)][_0x5281ba(0x94)](_0x37a1bc[_0x5281ba(0x2a1)]),_0x1779a6[_0x5281ba(0x8f)]&&Array[_0x5281ba(0x306)](_0x1779a6[_0x5281ba(0x8f)])&&(_0x1779a6[_0x5281ba(0x8f)][_0x5281ba(0xc7)]((_0x2bc917,_0x16ddc6)=>{const _0x413a46=_0x5281ba,_0x439bcb=String['fromCharCode'](0x41+_0x16ddc6),_0x2365fc=_0x37a1bc[_0x413a46(0xe2)](selectedOption,_0x16ddc6),_0x299016=document[_0x413a46(0x14b)](_0x37a1bc[_0x413a46(0x12e)]);_0x299016[_0x413a46(0x1f4)]=_0x413a46(0x160)+(_0x2365fc?_0x37a1bc[_0x413a46(0x1c3)]:'')+'\x22\x20data-option-index=\x22'+_0x16ddc6+_0x413a46(0x2cc)+_0x439bcb+_0x413a46(0x2ce)+(_0x2bc917['text']||_0x37a1bc[_0x413a46(0xd7)](_0x37a1bc[_0x413a46(0x295)],_0x37a1bc['ZCHrz'](_0x16ddc6,0x1)))+_0x413a46(0x266),_0x1b4e86[_0x413a46(0x222)](_0x299016);}),_0x1b4e86[_0x5281ba(0xc9)](_0x5281ba(0x2d5),function(_0x4981a9){const _0x2887b2=_0x5281ba,_0x56eac4={'wdbxY':function(_0x46780f,_0x52187e){const _0x1ad0fc=_0x3341;return _0x37a1bc[_0x1ad0fc(0x8d)](_0x46780f,_0x52187e);},'Irxte':_0x37a1bc['rPziT'],'AaXCn':function(_0x343a1c,_0x506187){const _0x9bfd19=_0x3341;return _0x37a1bc[_0x9bfd19(0xd7)](_0x343a1c,_0x506187);}};if('WzUMw'===_0x37a1bc[_0x2887b2(0x2c1)])_0x3df7bc(_0x37a1bc[_0x2887b2(0x226)])&&(_0x24edf9=0x0,_0x37a1bc[_0x2887b2(0x1e8)](_0x14c87d),_0x37a1bc['oMfHj'](_0x5193a4));else{const _0x4bab13=_0x4981a9['target']['closest'](_0x37a1bc[_0x2887b2(0x1e6)]);if(_0x4bab13){if(_0x37a1bc[_0x2887b2(0x2e1)](_0x37a1bc[_0x2887b2(0x2e2)],_0x37a1bc[_0x2887b2(0x2c3)])){const _0x1e213a=parseInt(_0x4bab13[_0x2887b2(0x1a9)](_0x37a1bc[_0x2887b2(0x28c)]));selectOption(_0x1e213a);}else{const _0xffa707=_0x13da18[_0x2887b2(0xa5)](_0x56eac4['wdbxY'](_0x2dc646,0x3c)),_0x239fc6=_0x3fcccb%0x3c;_0x3e62f4[_0x2887b2(0x106)](_0x56eac4[_0x2887b2(0x285)])[_0x2887b2(0x84)]=_0x56eac4['AaXCn'](_0xffa707+':',_0x239fc6[_0x2887b2(0x92)]()[_0x2887b2(0x82)](0x2,'0'));}}}})),_0x37a1bc[_0x5281ba(0xd8)](updateBookmarkButton),_0x37a1bc[_0x5281ba(0x105)](updateMarkReviewButton),(_0x37a1bc[_0x5281ba(0x188)](currentMode,_0x37a1bc[_0x5281ba(0x240)])||_0x37a1bc[_0x5281ba(0x264)](currentMode,_0x37a1bc[_0x5281ba(0xa4)]))&&!isQuizCompleted&&_0x37a1bc[_0x5281ba(0xd8)](startTimer);}function selectOption(_0x3687df){const _0x239f12=_0x5ae343,_0x292673={'IhLoG':function(_0x1c204b,_0x44e6d8){return _0x1c204b===_0x44e6d8;},'cahfs':_0x239f12(0x136),'zjGnZ':_0x239f12(0x2b1),'rOaUw':function(_0x456f12,_0x141932){return _0x456f12===_0x141932;},'azUXD':_0x239f12(0x311),'DvGul':function(_0x21fca7,_0x2e4cb9){return _0x21fca7-_0x2e4cb9;},'dShps':_0x239f12(0x202),'DXwTF':function(_0x3025bb,_0x5a095e){return _0x3025bb===_0x5a095e;},'gUJXd':_0x239f12(0x2d6),'ODxTI':function(_0x331f03,_0x31fa8f){return _0x331f03===_0x31fa8f;},'Cvdho':_0x239f12(0x1bf),'gtzPf':function(_0x5c68e6,_0xbde7a4){return _0x5c68e6!==_0xbde7a4;},'xysxS':function(_0x43e9fb){return _0x43e9fb();},'ppbdF':function(_0x5ad068,_0x462cb8){return _0x5ad068===_0x462cb8;},'ahZxP':function(_0x1a54ba){return _0x1a54ba();}},_0x7675ab=document[_0x239f12(0x106)](_0x292673[_0x239f12(0x19c)]);if(_0x7675ab[_0x239f12(0x27a)][_0x239f12(0x293)](_0x239f12(0x2ba)))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x239f12(0x174)]+=_0x292673[_0x239f12(0xfc)](Date['now'](),questionStartTime),questionStartTime=Date['now']()),selectedOption=_0x3687df,questionStates[currentQuestionIndex]['selectedAnswer']=_0x3687df,document[_0x239f12(0x1ee)](_0x292673['dShps'])[_0x239f12(0xc7)]((_0x341110,_0x235054)=>{const _0x1361c2=_0x239f12;if(_0x292673['IhLoG'](_0x1361c2(0x136),_0x292673[_0x1361c2(0x209)]))_0x341110[_0x1361c2(0x27a)][_0x1361c2(0x1b0)](_0x292673[_0x1361c2(0x30d)],_0x292673[_0x1361c2(0x1a8)](_0x235054,_0x3687df));else{_0xee4ff5['totalAttempted']++,_0x19c595[_0x1361c2(0x31e)]--;if(_0x18dbfe)_0xa1e77a[_0x1361c2(0xbc)]++;else _0x505f3f[_0x1361c2(0x197)]++;}}),_0x292673[_0x239f12(0x296)](currentMode,_0x292673[_0x239f12(0x10b)])||_0x292673[_0x239f12(0x11b)](currentMode,_0x292673['Cvdho'])?_0x292673['gtzPf'](_0x239f12(0x8e),_0x239f12(0x8e))?(_0x292673['rOaUw'](_0x26366a[_0x314630]['status'],_0x239f12(0x13d))&&(_0x22cd26[_0x5a0f70][_0x239f12(0x95)]='answered',_0x3af9c6[_0x239f12(0x255)]++,_0x1b5ce0[_0x239f12(0x31e)]--),_0x4e53df()):_0x292673[_0x239f12(0xaf)](processAnswer):(_0x292673['ppbdF'](questionStates[currentQuestionIndex][_0x239f12(0x95)],_0x239f12(0x13d))&&(questionStates[currentQuestionIndex][_0x239f12(0x95)]='answered',stats[_0x239f12(0x255)]++,stats[_0x239f12(0x31e)]--),_0x292673[_0x239f12(0x14a)](updateQuestionNav)),saveProgress();}function processAnswer(){const _0x45b117=_0x5ae343,_0x38aaf8={'aelvW':function(_0x4229ae,_0x45ec0d){return _0x4229ae===_0x45ec0d;},'JLsBn':function(_0x56b9fa,_0x36d27f){return _0x56b9fa===_0x36d27f;},'LFLyq':function(_0x49f82e,_0xec1c98){return _0x49f82e===_0xec1c98;},'ArKUJ':_0x45b117(0x13d),'zneyD':_0x45b117(0xbd),'XvAdE':_0x45b117(0xff),'hnlkD':function(_0x573ca7){return _0x573ca7();},'KQaWl':function(_0x275d88,_0x4ee6ff){return _0x275d88(_0x4ee6ff);}},_0x3c8bcc=questionsData[currentQuestionIndex],_0x33831e=_0x3c8bcc['correct_choice_id'];if(_0x38aaf8['aelvW'](selectedOption,null))return;const _0x18f5eb=_0x3c8bcc[_0x45b117(0x8f)][selectedOption],_0x37a443=_0x38aaf8[_0x45b117(0x286)](_0x18f5eb['id'],_0x33831e);if(_0x38aaf8[_0x45b117(0x20b)](questionStates[currentQuestionIndex][_0x45b117(0x95)],_0x38aaf8[_0x45b117(0x28a)])){stats[_0x45b117(0x255)]++,stats[_0x45b117(0x31e)]--;if(_0x37a443)stats[_0x45b117(0xbc)]++;else stats[_0x45b117(0x197)]++;}questionStates[currentQuestionIndex][_0x45b117(0x95)]=_0x37a443?_0x38aaf8[_0x45b117(0xed)]:_0x38aaf8['XvAdE'],_0x38aaf8[_0x45b117(0xa7)](updateStats),_0x38aaf8[_0x45b117(0x22d)](showInlineFeedback,_0x37a443),updateQuestionNav();}function showInlineFeedback(_0x2c6b73){const _0xee615f=_0x5ae343,_0x1a34a2={'TzjRp':_0xee615f(0x2b1),'ECgJK':function(_0x1664bf,_0x301152){return _0x1664bf===_0x301152;},'QLRMC':'correct','DONmW':_0xee615f(0xff),'WVfhp':'study','WKUcW':function(_0x540c00,_0x536e52){return _0x540c00!==_0x536e52;},'RgRpu':_0xee615f(0x1bf),'bTpql':_0xee615f(0x311),'puivB':_0xee615f(0x202),'ATvnI':_0xee615f(0x2ba),'aSEbh':function(_0x261af6){return _0x261af6();}};if(currentMode!==_0x1a34a2['WVfhp']&&_0x1a34a2['WKUcW'](currentMode,_0x1a34a2[_0xee615f(0x150)]))return;const _0x51e978=document[_0xee615f(0x106)](_0x1a34a2[_0xee615f(0x157)]),_0x3f00ad=_0x51e978[_0xee615f(0x1ee)](_0x1a34a2[_0xee615f(0x2c8)]),_0x710fe=questionsData[currentQuestionIndex],_0x3886e7=_0x710fe[_0xee615f(0x13e)];let _0x5cb481=_0x710fe[_0xee615f(0x8f)][_0xee615f(0x167)](_0x31a50b=>_0x31a50b['id']===_0x3886e7);_0x51e978[_0xee615f(0x27a)][_0xee615f(0x253)](_0x1a34a2[_0xee615f(0x26c)]),_0x3f00ad[_0xee615f(0xc7)]((_0x3596c6,_0xd568bc)=>{const _0x5749c4=_0xee615f;_0x3596c6[_0x5749c4(0x27a)][_0x5749c4(0x94)](_0x1a34a2[_0x5749c4(0x247)]);if(_0x1a34a2[_0x5749c4(0x2a8)](_0xd568bc,_0x5cb481))_0x3596c6[_0x5749c4(0x27a)]['add'](_0x1a34a2['QLRMC']);else{if(_0x1a34a2[_0x5749c4(0x2a8)](_0xd568bc,selectedOption)&&!_0x2c6b73)_0x3596c6['classList']['add'](_0x1a34a2[_0x5749c4(0x14e)]);}}),_0x1a34a2[_0xee615f(0x2b8)](showSolution);}function showSolution(){const _0x121766=_0x5ae343,_0x191123={'VJtXn':function(_0x404c4c,_0x4df3fc){return _0x404c4c!==_0x4df3fc;},'VEfRZ':_0x121766(0x1bf),'dhtZe':_0x121766(0xfa),'FJiFf':'No\x20solution\x20provided','HuFDx':'solutionVideo','DDKmM':'explanationVideoPlayer','UzNaU':_0x121766(0x227),'vcNLm':function(_0x4d909b,_0x49ea6c,_0x3d6588){return _0x4d909b(_0x49ea6c,_0x3d6588);},'GmPQu':_0x121766(0x1e2),'adYvC':'solutionAudio','DqNzs':'solutionImages','KoHzN':_0x121766(0x30c)};if(_0x191123[_0x121766(0x317)](currentMode,_0x121766(0x2d6))&&currentMode!==_0x191123[_0x121766(0x9b)])return;const _0x57bf8c=questionsData[currentQuestionIndex];document[_0x121766(0x106)](_0x191123[_0x121766(0x333)])[_0x121766(0x1f4)]=_0x57bf8c[_0x121766(0x146)]||_0x191123['FJiFf'];const _0x4c8d2e=document['getElementById'](_0x191123['HuFDx']),_0x3650a0=document[_0x121766(0x106)](_0x191123['DDKmM']),_0xc4bd02=_0x57bf8c[_0x121766(0xc1)];if(_0xc4bd02){_0x4c8d2e[_0x121766(0x27a)]['remove']('hidden');if(_0xc4bd02[_0x121766(0x11f)](_0x191123[_0x121766(0x2eb)]))_0x191123[_0x121766(0x155)](setupVideo,_0x3650a0,_0xc4bd02);else _0x3650a0['src']=_0xc4bd02;}else _0x4c8d2e[_0x121766(0x27a)][_0x121766(0x253)](_0x191123[_0x121766(0x142)]);const _0x12a56a=document['getElementById'](_0x191123[_0x121766(0x239)]);_0x12a56a[_0x121766(0x1f4)]='';_0x57bf8c[_0x121766(0xfd)]&&(_0x12a56a[_0x121766(0x1f4)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x57bf8c[_0x121766(0xfd)]+_0x121766(0x138));_0x57bf8c[_0x121766(0xd3)]&&(_0x12a56a[_0x121766(0x1f4)]+=_0x121766(0x86)+_0x57bf8c[_0x121766(0xd3)]+_0x121766(0x138));const _0x328335=document[_0x121766(0x106)](_0x191123['DqNzs']);_0x328335[_0x121766(0x1f4)]='',_0x57bf8c['explanation_images']&&_0x57bf8c[_0x121766(0x23c)][_0x121766(0xc7)](_0x1e6654=>{const _0x4bc362=_0x121766;if(_0x1e6654)_0x328335[_0x4bc362(0x1f4)]+=_0x4bc362(0x205)+_0x1e6654+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}),document['getElementById'](_0x191123[_0x121766(0x16d)])['classList'][_0x121766(0x94)](_0x121766(0x1e2));}function submitQuiz(){const _0x4f893e=_0x5ae343,_0x371610={'iCsEe':'correct','UGHsF':_0x4f893e(0xff),'IAQdj':function(_0x564001,_0x55ffa2){return _0x564001!==_0x55ffa2;},'eWWhx':_0x4f893e(0x1bf),'qFkSE':'optionsContainer','puDvi':_0x4f893e(0x202),'CZvZp':_0x4f893e(0x2ba),'iEfKA':function(_0x167d4d){return _0x167d4d();},'SeXPG':function(_0x512db9,_0x288c24){return _0x512db9===_0x288c24;},'eWFYC':_0x4f893e(0x2f5),'sWeVb':function(_0x3275ce,_0x235ca8){return _0x3275ce(_0x235ca8);},'WcdlX':_0x4f893e(0x1d8),'nBeml':_0x4f893e(0xc0),'iXMRf':function(_0x6b38a2,_0x129b96){return _0x6b38a2-_0x129b96;},'KbNLN':function(_0x6fa213,_0x10d32b){return _0x6fa213+_0x10d32b;},'fQacy':function(_0x232b81,_0x32949c){return _0x232b81-_0x32949c;}};if(timer)_0x371610[_0x4f893e(0x301)](clearInterval,timer);if(!_0x371610[_0x4f893e(0x301)](confirm,_0x371610[_0x4f893e(0x184)]))return;isQuizCompleted=!![];let _0x214360=0x0,_0x42641d=0x0;const _0x1eb13d=Date[_0x4f893e(0xc2)]()-quizStartTime;questionsData[_0x4f893e(0xc7)]((_0x40d3b4,_0x1fed52)=>{const _0xff854b=_0x4f893e;if(_0x371610[_0xff854b(0x17c)](_0xff854b(0x1f2),_0xff854b(0x2e5))){const _0x41ff03=questionStates[_0x1fed52];if(_0x371610[_0xff854b(0x17c)](_0x41ff03[_0xff854b(0xab)],null)){if(_0x371610[_0xff854b(0x81)](_0x40d3b4['choices'][_0x41ff03[_0xff854b(0xab)]]['id'],_0x40d3b4[_0xff854b(0x13e)]))_0x214360++,_0x41ff03[_0xff854b(0x95)]=_0x371610[_0xff854b(0x2dd)];else{if(_0x371610[_0xff854b(0x17c)](_0xff854b(0x2f5),_0x371610[_0xff854b(0x20a)])){if(_0x268ec2){const _0x1d54b5=_0x44016b[_0xff854b(0x2c0)](_0x54f17d,arguments);return _0x4e11fc=null,_0x1d54b5;}}else _0x42641d++,_0x41ff03[_0xff854b(0x95)]=_0x371610[_0xff854b(0x287)];}}}else{const _0x7f63a6={'yDgnL':function(_0x41f177,_0x54eca3){return _0x41f177===_0x54eca3;},'Zcnup':_0x371610[_0xff854b(0x2dd)],'vhNfS':function(_0x221498,_0x5267a1){return _0x221498===_0x5267a1;},'BqaWM':_0x371610[_0xff854b(0x287)]};if(_0x371610[_0xff854b(0x17c)](_0x1e1191,_0xff854b(0x2d6))&&_0x3f2cb8!==_0x371610[_0xff854b(0x9f)])return;const _0x4bac3e=_0x42f560[_0xff854b(0x106)](_0x371610[_0xff854b(0x2a4)]),_0x3ab498=_0x4bac3e[_0xff854b(0x1ee)](_0x371610['puDvi']),_0x10dfcb=_0x12dfb4[_0x36fcda],_0x298566=_0x10dfcb[_0xff854b(0x13e)];let _0xe661a3=_0x10dfcb[_0xff854b(0x8f)][_0xff854b(0x167)](_0x46896b=>_0x46896b['id']===_0x298566);_0x4bac3e[_0xff854b(0x27a)][_0xff854b(0x253)](_0x371610[_0xff854b(0x1ad)]),_0x3ab498[_0xff854b(0xc7)]((_0x3ff2f5,_0x4dba61)=>{const _0x27c072=_0xff854b;_0x3ff2f5[_0x27c072(0x27a)][_0x27c072(0x94)](_0x27c072(0x2b1));if(_0x7f63a6[_0x27c072(0x2c6)](_0x4dba61,_0xe661a3))_0x3ff2f5[_0x27c072(0x27a)][_0x27c072(0x253)](_0x7f63a6[_0x27c072(0xa3)]);else{if(_0x7f63a6[_0x27c072(0x269)](_0x4dba61,_0x3fe0b6)&&!_0x1452fe)_0x3ff2f5[_0x27c072(0x27a)][_0x27c072(0x253)](_0x7f63a6['BqaWM']);}}),_0x371610['iEfKA'](_0x3c8815);}});const _0x3b9bac=JSON[_0x4f893e(0x1a3)](localStorage['getItem'](_0x371610[_0x4f893e(0x88)]))||[];_0x3b9bac[_0x4f893e(0x2e3)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x4f893e(0xc2)](),'totalTime':_0x1eb13d,'stats':{'correct':_0x214360,'incorrect':_0x42641d,'notAttempted':_0x371610['iXMRf'](questionsData[_0x4f893e(0x18e)],_0x371610[_0x4f893e(0x154)](_0x214360,_0x42641d))}}),localStorage[_0x4f893e(0x203)](_0x371610[_0x4f893e(0x88)],JSON[_0x4f893e(0x2c9)](_0x3b9bac)),stats[_0x4f893e(0xbc)]=_0x214360,stats[_0x4f893e(0x197)]=_0x42641d,_0x371610[_0x4f893e(0x148)](markQuizAsCompleted),showPerformanceAnalysis(_0x214360,_0x42641d,_0x371610[_0x4f893e(0x283)](questionsData[_0x4f893e(0x18e)],_0x214360+_0x42641d),_0x1eb13d);}function showPerformanceAnalysis(_0x522f45,_0x3888b2,_0x17c15a,_0x4bce6a){const _0xf8e361=_0x5ae343,_0x3137ad={'IAMuh':function(_0x487ff0,_0x597179){return _0x487ff0>_0x597179;},'kEAkX':function(_0x262529,_0x48348b){return _0x262529+_0x48348b;},'QMiFa':function(_0x2aa6bc,_0x1ecc1a){return _0x2aa6bc*_0x1ecc1a;},'sNJSy':function(_0x1a2f83,_0x126736){return _0x1a2f83*_0x126736;},'MnIwa':function(_0x8a6c1f,_0x5ef828){return _0x8a6c1f-_0x5ef828;},'AXGIm':function(_0x462adc,_0x2af98d){return _0x462adc/_0x2af98d;},'JXRgD':_0xf8e361(0xbb),'RzjOZ':_0xf8e361(0x1ba),'lCAIt':'incorrectResult','urSnE':function(_0x5e002b,_0x464658){return _0x5e002b%_0x464658;},'zqwHg':_0xf8e361(0x100),'mkUwn':function(_0x3400a6,_0x17b5f1){return _0x3400a6/_0x17b5f1;},'uWJke':function(_0x2e2119,_0xf00224){return _0x2e2119/_0xf00224;},'lMoha':'avgTimeResult','EJhbe':_0xf8e361(0x1e2)},_0x10f08d=document[_0xf8e361(0x106)](_0xf8e361(0x10d)),_0x2147df=_0x3137ad[_0xf8e361(0x125)](_0x3137ad['kEAkX'](_0x522f45,_0x3888b2),0x0)?Math[_0xf8e361(0x318)](_0x3137ad[_0xf8e361(0xa2)](_0x522f45/(_0x522f45+_0x3888b2),0x64)):0x0,_0x5937cb=_0x3137ad[_0xf8e361(0xa2)](_0x3137ad[_0xf8e361(0xe9)](0x2,Math['PI']),0x41),_0x331351=document[_0xf8e361(0x106)](_0xf8e361(0x1cc));_0x331351[_0xf8e361(0xf3)][_0xf8e361(0xa6)]=_0x5937cb+'\x20'+_0x5937cb,_0x331351['style'][_0xf8e361(0xbe)]=_0x3137ad[_0xf8e361(0x2b5)](_0x5937cb,_0x3137ad[_0xf8e361(0xa2)](_0x3137ad[_0xf8e361(0xfb)](_0x2147df,0x64),_0x5937cb)),document[_0xf8e361(0x106)](_0xf8e361(0xce))[_0xf8e361(0x84)]=_0x2147df+'%',document[_0xf8e361(0x106)](_0x3137ad[_0xf8e361(0xdc)])[_0xf8e361(0x84)]=questionsData[_0xf8e361(0x18e)],document[_0xf8e361(0x106)](_0x3137ad['RzjOZ'])[_0xf8e361(0x84)]=_0x522f45,document['getElementById'](_0x3137ad[_0xf8e361(0x341)])[_0xf8e361(0x84)]=_0x3888b2,document[_0xf8e361(0x106)](_0xf8e361(0x1d7))[_0xf8e361(0x84)]=_0x17c15a;const _0x32ac88=Math['floor'](_0x4bce6a/0xea60),_0x59a2bc=Math[_0xf8e361(0xa5)](_0x3137ad['urSnE'](_0x4bce6a,0xea60)/0x3e8);document[_0xf8e361(0x106)](_0x3137ad[_0xf8e361(0x1d2)])['textContent']=_0x32ac88+':'+_0x59a2bc['toString']()[_0xf8e361(0x82)](0x2,'0');const _0xccb10d=_0x3137ad[_0xf8e361(0x22a)](_0x4bce6a,questionsData[_0xf8e361(0x18e)]),_0x3fa0c9=Math[_0xf8e361(0xa5)](_0x3137ad[_0xf8e361(0xfb)](_0xccb10d,0xea60)),_0x4a2c7a=Math[_0xf8e361(0xa5)](_0x3137ad['uWJke'](_0x3137ad[_0xf8e361(0x1d6)](_0xccb10d,0xea60),0x3e8));document[_0xf8e361(0x106)](_0x3137ad['lMoha'])[_0xf8e361(0x84)]=_0x3fa0c9+':'+_0x4a2c7a[_0xf8e361(0x92)]()[_0xf8e361(0x82)](0x2,'0'),_0x10f08d[_0xf8e361(0x27a)][_0xf8e361(0x94)](_0x3137ad[_0xf8e361(0x170)]);}function closePerformanceModal(){const _0x7ee574=_0x5ae343,_0x801391={'TuNdL':'performanceModal','aPLrk':'hidden'};document[_0x7ee574(0x106)](_0x801391['TuNdL'])[_0x7ee574(0x27a)][_0x7ee574(0x253)](_0x801391['aPLrk']);}function reviewQuestions(){const _0x422cca=_0x5ae343,_0x4b45ad={'wzxGI':_0x422cca(0x1ea),'FjHJy':_0x422cca(0x89),'ziGQd':function(_0x5e602f,_0x5cebbf){return _0x5e602f+_0x5cebbf;},'VDwfU':'\x20-\x20Brain\x20And\x20Scalpel','gLpDN':_0x422cca(0xff),'JLOtX':_0x422cca(0x24d),'UuxfF':_0x422cca(0x29a),'okNMS':function(_0x1fc10a,_0x39c384){return _0x1fc10a===_0x39c384;},'diUhB':function(_0x500148,_0x39805f){return _0x500148===_0x39805f;},'BJeKd':_0x422cca(0x1fb),'WefJP':_0x422cca(0x219),'YYidT':function(_0x58062a,_0x11be90){return _0x58062a(_0x11be90);},'ySPmc':_0x422cca(0x182),'Vznau':function(_0x23921c){return _0x23921c();},'OlGXa':_0x422cca(0x21a),'wdxCg':function(_0x211592,_0x2a6147){return _0x211592!==_0x2a6147;},'XcXXb':_0x422cca(0x17d),'wqDXt':function(_0x419e53,_0x1cebad){return _0x419e53===_0x1cebad;},'EwnUB':_0x422cca(0x310),'MGAVv':_0x422cca(0xbd),'seFCc':_0x422cca(0x214),'FSdmM':_0x422cca(0x128),'AnmjV':_0x422cca(0x29c),'TYvJw':_0x422cca(0x268),'PVrau':function(_0x238c19,_0x3a3b08){return _0x238c19===_0x3a3b08;},'sxXmL':_0x422cca(0x243),'VEgDL':_0x422cca(0x32a),'tPaSo':_0x422cca(0x231),'zIccm':_0x422cca(0x30f),'qUhtz':_0x422cca(0x1e2)};document['getElementById'](_0x4b45ad[_0x422cca(0x126)])[_0x422cca(0x27a)][_0x422cca(0x94)](_0x4b45ad[_0x422cca(0x217)]);const _0x4ff2d8=document[_0x422cca(0x106)](_0x422cca(0x137));_0x4ff2d8[_0x422cca(0x1f4)]='',questionsData[_0x422cca(0xc7)]((_0x8967a8,_0x570013)=>{const _0x69ea10=_0x422cca,_0x737b59={'MDMWG':function(_0x5ab683,_0x1c7d37){const _0x369a58=_0x3341;return _0x4b45ad[_0x369a58(0x2ec)](_0x5ab683,_0x1c7d37);},'YVMPz':_0x4b45ad['ySPmc'],'uyOAN':function(_0xa24b90,_0x3fe7cb){return _0xa24b90(_0x3fe7cb);},'udFvb':function(_0x178815){const _0x5ee2d4=_0x3341;return _0x4b45ad[_0x5ee2d4(0xd1)](_0x178815);},'vPatM':function(_0x500adf){const _0x517af4=_0x3341;return _0x4b45ad[_0x517af4(0xd1)](_0x500adf);}},_0x5d44f3=questionStates[_0x570013],_0x5b5576=_0x8967a8[_0x69ea10(0x13e)];let _0x287504=_0x4b45ad[_0x69ea10(0xda)],_0xb430b0='Not\x20Attempted';if(_0x4b45ad[_0x69ea10(0x1e4)](_0x5d44f3['selectedAnswer'],null)){if(_0x4b45ad[_0x69ea10(0xef)](_0x4b45ad[_0x69ea10(0x1fc)],'YigMp')){const _0x558bb3=_0x8967a8[_0x69ea10(0x8f)][_0x5d44f3['selectedAnswer']];if(_0x4b45ad[_0x69ea10(0x2bd)](_0x558bb3['id'],_0x5b5576)){if(_0x4b45ad[_0x69ea10(0x319)]('QXMZa',_0x4b45ad['EwnUB']))_0x287504=_0x4b45ad['MGAVv'],_0xb430b0=_0x4b45ad[_0x69ea10(0x1b5)];else{const _0x5e1d96=_0x1aeda8['parse'](_0x543499[_0x69ea10(0x2e0)](_0x4b45ad[_0x69ea10(0x166)]));if(_0x5e1d96){const _0x3c913c=_0x4b45ad[_0x69ea10(0x133)][_0x69ea10(0x25a)]('|');let _0x27d3b5=0x0;while(!![]){switch(_0x3c913c[_0x27d3b5++]){case'0':_0x23a828[_0x69ea10(0x106)]('quizHierarchy')[_0x69ea10(0x84)]=_0x22eb4b[_0x69ea10(0x33f)](_0x69ea10(0x2b7));continue;case'1':_0x82de0[_0x69ea10(0x106)](_0x69ea10(0xf1))[_0x69ea10(0x84)]=_0x4193e1[_0x69ea10(0x18e)];continue;case'2':_0x54e9fe[_0x69ea10(0x199)]=_0x4b45ad[_0x69ea10(0x2ac)](_0x1e39c6,_0x4b45ad['VDwfU']);continue;case'3':_0x2bb935=_0x5e1d96[_0x69ea10(0x19b)];continue;case'4':_0x1d1911=_0x5e1d96['questions'];continue;case'5':_0x54675b=_0x5e1d96[_0x69ea10(0x83)];continue;}break;}}}}else{if(_0x4b45ad[_0x69ea10(0x1e4)]('jLwSr',_0x4b45ad['FSdmM']))_0x287504=_0x4b45ad[_0x69ea10(0x249)],_0xb430b0=_0x4b45ad[_0x69ea10(0xcc)];else{const _0x3c984f=_0x737b59[_0x69ea10(0x1ec)](_0x500c5f,_0x4eea24[_0x69ea10(0x1a9)](_0x737b59[_0x69ea10(0x339)]));_0x737b59[_0x69ea10(0x2fb)](_0xf495ed,_0x3c984f);}}}else _0xfa84c9=0x0,_0x737b59[_0x69ea10(0x267)](_0x353703),_0x737b59[_0x69ea10(0xf0)](_0x5db0a6);}const _0x260363=document[_0x69ea10(0x14b)](_0x4b45ad['AnmjV']);_0x260363[_0x69ea10(0x2a0)]=_0x69ea10(0x1dc)+_0x287504;let _0x180da5=(_0x8967a8['choices']||[])['map']((_0x1531f4,_0x1169ad)=>{const _0xd587db=_0x69ea10,_0x52a4e2={'CeWtd':_0x4b45ad[_0xd587db(0x249)],'KScyH':_0x4b45ad[_0xd587db(0xcc)]};if(_0x4b45ad[_0xd587db(0x169)]===_0xd587db(0x29a)){const _0x52bb89=_0x4b45ad['okNMS'](_0x5d44f3['selectedAnswer'],_0x1169ad),_0x905a0e=_0x4b45ad[_0xd587db(0xef)](_0x1531f4['id'],_0x5b5576);let _0x52c405=_0x4b45ad[_0xd587db(0x2ee)];if(_0x905a0e)_0x52c405=_0x4b45ad[_0xd587db(0xac)];else{if(_0x52bb89)_0x52c405='border-red-500';}return _0xd587db(0x328)+_0x52c405+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String[_0xd587db(0x313)](_0x4b45ad[_0xd587db(0x2ac)](0x41,_0x1169ad))+_0xd587db(0x273)+_0x1531f4[_0xd587db(0x1c7)]+_0xd587db(0x9d);}else _0x1ba4a2=_0x52a4e2['CeWtd'],_0x5706e6=_0x52a4e2[_0xd587db(0x2af)];})[_0x69ea10(0x33f)]('');const _0x2b8328=_0x8967a8[_0x69ea10(0xc1)]?'<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-'+_0x570013+_0x69ea10(0x335)+_0x8967a8[_0x69ea10(0xc1)]+_0x69ea10(0x2d4):'';let _0x10fded='';if(_0x8967a8[_0x69ea10(0xfd)])_0x10fded+=_0x69ea10(0x233)+_0x8967a8[_0x69ea10(0xfd)]+_0x69ea10(0x138);if(_0x8967a8[_0x69ea10(0xd3)])_0x10fded+=_0x69ea10(0xe4)+_0x8967a8['explanation_audio_hin']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x2f4210=(_0x8967a8[_0x69ea10(0x23c)]||[])['map'](_0x3a8714=>_0x3a8714?_0x69ea10(0x205)+_0x3a8714+_0x69ea10(0x2fd):'')[_0x69ea10(0x33f)]('');_0x260363[_0x69ea10(0x1f4)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x4b45ad[_0x69ea10(0x2ac)](_0x570013,0x1)+_0x69ea10(0x196)+(_0x287504===_0x69ea10(0xbd)?_0x4b45ad[_0x69ea10(0x2bb)]:_0x4b45ad[_0x69ea10(0x1ca)](_0x287504,_0x4b45ad[_0x69ea10(0x249)])?_0x4b45ad[_0x69ea10(0x127)]:_0x4b45ad[_0x69ea10(0x8b)])+'-600\x20text-white\x22>'+_0xb430b0+_0x69ea10(0x1b4)+_0x8967a8[_0x69ea10(0x1c7)]+_0x69ea10(0x2fe)+_0x180da5+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x8967a8[_0x69ea10(0x146)]||_0x4b45ad[_0x69ea10(0x21d)])+_0x69ea10(0x17a)+_0x2b8328+_0x69ea10(0x228)+_0x10fded+_0x69ea10(0x228)+_0x2f4210+_0x69ea10(0x2f1),_0x4ff2d8[_0x69ea10(0x222)](_0x260363);}),_0x4b45ad[_0x422cca(0xd1)](initializeReviewVideos);}function initializeReviewVideos(){const _0x239db6=_0x5ae343,_0x48e8bb={'HErkO':'nav-btn-current','zmpoe':function(_0x2c603b,_0x2940e,_0x925a80){return _0x2c603b(_0x2940e,_0x925a80);},'vRkaT':function(_0x14fb35,_0x5b9371){return _0x14fb35!==_0x5b9371;},'ioiSx':_0x239db6(0x1a6)};document[_0x239db6(0x1ee)](_0x239db6(0x16b))[_0x239db6(0xc7)](_0x387747=>{const _0x4139dc=_0x239db6,_0x3174cc=_0x387747[_0x4139dc(0x1db)][_0x4139dc(0x251)];if(_0x3174cc&&_0x3174cc[_0x4139dc(0x11f)]('.m3u8'))_0x48e8bb[_0x4139dc(0x1ff)](setupVideo,_0x387747,_0x3174cc);else _0x3174cc&&(_0x48e8bb[_0x4139dc(0x13b)](_0x4139dc(0x1a6),_0x48e8bb[_0x4139dc(0x119)])?_0x2fafaa=_0x48e8bb[_0x4139dc(0xd2)]:_0x387747[_0x4139dc(0x251)]=_0x3174cc);});}function retakeQuiz(){const _0xab20ad=_0x5ae343,_0x448ed8={'UKAKW':_0xab20ad(0x344),'BMiRe':function(_0x372b52,_0x52b092){return _0x372b52!==_0x52b092;},'kkcbP':_0xab20ad(0x260),'xZTxt':'custom_quiz.html','jHEQt':function(_0x57ddfb){return _0x57ddfb();}};if(confirm(_0x448ed8[_0xab20ad(0x326)])){if(_0x448ed8[_0xab20ad(0xf7)](_0x448ed8[_0xab20ad(0x1d4)],_0x448ed8['kkcbP'])){if(_0x1b5ffa['isSupported']()){const _0x81b2ef=new _0x4b4879();_0x81b2ef['loadSource'](_0x2c7bf5),_0x81b2ef['attachMedia'](_0x251af0);}else _0x19bab9[_0xab20ad(0x324)](_0xab20ad(0xe6))&&(_0x19647a['src']=_0x47af9d);}else window[_0xab20ad(0x1be)]['pathname'][_0xab20ad(0x1a2)](_0x448ed8[_0xab20ad(0x300)])&&localStorage['removeItem'](_0xab20ad(0x1ea)),_0x448ed8[_0xab20ad(0x284)](clearProgress),location[_0xab20ad(0xba)]();}}function loadBookmarkedQuestions(){const _0x4fc5a0=_0x5ae343,_0x8d27f={'xHrag':_0x4fc5a0(0x1e2),'ZROCy':_0x4fc5a0(0x227),'KmPSE':function(_0x155dce,_0x21e960){return _0x155dce===_0x21e960;},'ofCbX':_0x4fc5a0(0x18a),'COYGT':function(_0x4576f0,_0x262494){return _0x4576f0<_0x262494;}},_0x1ba081=JSON[_0x4fc5a0(0x1a3)](localStorage[_0x4fc5a0(0x2e0)](_0x4fc5a0(0x152)))||[];_0x1ba081[_0x4fc5a0(0xc7)](_0x5df2ef=>{const _0x25c604=_0x4fc5a0,_0x3f17a5={'DpZjT':_0x8d27f[_0x25c604(0xd9)],'ujHDp':_0x8d27f['ZROCy']};if(_0x5df2ef['quizFile'][_0x25c604(0x11f)](quizName['toLowerCase']()[_0x25c604(0x112)](/ /g,'-'))){if(_0x8d27f[_0x25c604(0x17e)](_0x25c604(0x27c),_0x8d27f[_0x25c604(0x1f1)])){_0x25e5e4[_0x25c604(0x27a)][_0x25c604(0x94)](_0x3f17a5[_0x25c604(0x191)]);if(_0xe0ce35[_0x25c604(0x11f)](_0x3f17a5['ujHDp']))_0x1afe1a(_0xd4a333,_0x155ab7);else _0x57ddf7['src']=_0x320f36;}else _0x8d27f[_0x25c604(0x332)](_0x5df2ef[_0x25c604(0xd4)],questionsData[_0x25c604(0x18e)])&&(questionStates[_0x5df2ef[_0x25c604(0xd4)]][_0x25c604(0x173)]=!![]);}});}function toggleBookmark(){const _0x193d1f=_0x5ae343,_0x35b080={'fkNrP':_0x193d1f(0x202),'hiGBL':function(_0x38f16f,_0x5814d8){return _0x38f16f(_0x5814d8);},'tZMSN':_0x193d1f(0x182),'HulmE':_0x193d1f(0x152),'KQTQf':function(_0x496483,_0x59b876){return _0x496483!==_0x59b876;},'xMZKu':function(_0xf8b370){return _0xf8b370();},'NXByY':function(_0x5d24fa){return _0x5d24fa();}},_0x24d5da=!questionStates[currentQuestionIndex][_0x193d1f(0x173)];questionStates[currentQuestionIndex][_0x193d1f(0x173)]=_0x24d5da;let _0x41ca06=JSON[_0x193d1f(0x1a3)](localStorage[_0x193d1f(0x2e0)](_0x35b080['HulmE']))||[];if(_0x24d5da){if(_0x35b080['KQTQf']('NFLlL',_0x193d1f(0x2cb))){const _0x522382=_0x36c848[_0x193d1f(0x85)][_0x193d1f(0x2b3)](_0x35b080[_0x193d1f(0x20f)]);if(_0x522382){const _0x1822f5=_0x35b080[_0x193d1f(0x22e)](_0x48a1eb,_0x522382[_0x193d1f(0x1a9)](_0x35b080[_0x193d1f(0x107)]));_0x35b080['hiGBL'](_0x47f72a,_0x1822f5);}}else{const _0x268ca0={'quizName':quizName,'quizFile':window[_0x193d1f(0x1be)][_0x193d1f(0x30b)][_0x193d1f(0x25a)]('/')[_0x193d1f(0x122)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x193d1f(0xc2)]()};_0x41ca06[_0x193d1f(0x2e3)](_0x268ca0);}}else _0x41ca06=_0x41ca06[_0x193d1f(0x263)](_0x1fb0b3=>!(_0x1fb0b3['quizFile']['includes'](quizName[_0x193d1f(0x23d)]()[_0x193d1f(0x112)](/ /g,'-'))&&_0x1fb0b3[_0x193d1f(0xd4)]===currentQuestionIndex));localStorage[_0x193d1f(0x203)](_0x35b080[_0x193d1f(0x164)],JSON[_0x193d1f(0x2c9)](_0x41ca06)),_0x35b080[_0x193d1f(0x113)](updateBookmarkButton),_0x35b080['NXByY'](updateQuestionNav);}function updateBookmarkButton(){const _0x769efa=_0x5ae343,_0x4db904={'OVrPi':_0x769efa(0x16e),'QPUrP':_0x769efa(0x8a),'ZSpSR':_0x769efa(0x10e)},_0xb0428d=document[_0x769efa(0x106)](_0x4db904[_0x769efa(0x18d)]),_0x50ef71=document[_0x769efa(0x106)](_0x769efa(0x99)),_0x21b95d=questionStates[currentQuestionIndex][_0x769efa(0x173)];_0xb0428d[_0x769efa(0x2a0)]=_0x21b95d?_0x4db904[_0x769efa(0x338)]:_0x769efa(0xc4),_0x50ef71[_0x769efa(0x84)]=_0x21b95d?_0x4db904[_0x769efa(0x346)]:_0x769efa(0x198);}function toggleMarkForReview(){const _0x142356=_0x5ae343;questionStates[currentQuestionIndex][_0x142356(0x186)]=!questionStates[currentQuestionIndex][_0x142356(0x186)],updateMarkReviewButton(),updateQuestionNav();}function updateMarkReviewButton(){const _0x26fc86=_0x5ae343,_0x376cf3={'CLuKV':_0x26fc86(0xb4),'kYjyf':_0x26fc86(0x104),'JMBCf':_0x26fc86(0x1f9)},_0x3eb37e=document[_0x26fc86(0x106)](_0x376cf3[_0x26fc86(0x187)]),_0x49a391=document['getElementById'](_0x26fc86(0x297)),_0x234185=questionStates[currentQuestionIndex][_0x26fc86(0x186)];_0x3eb37e[_0x26fc86(0x2a0)]=_0x234185?_0x26fc86(0x2df):_0x26fc86(0x2cf),_0x49a391[_0x26fc86(0x84)]=_0x234185?_0x376cf3[_0x26fc86(0x22b)]:_0x376cf3['JMBCf'];}function previousQuestion(){const _0x4bacb4=_0x5ae343,_0x3d24aa={'OIYAP':function(_0x3e1813){return _0x3e1813();},'UgPZB':function(_0x21510b,_0x4d48bc){return _0x21510b>_0x4d48bc;},'iDhrD':function(_0x4909d0,_0x39a9bd){return _0x4909d0!==_0x39a9bd;},'MJVTy':_0x4bacb4(0x2a9),'fMBZn':_0x4bacb4(0x27d),'nMzgB':'wHxfK','CbRGa':_0x4bacb4(0x1c1),'YDfnM':function(_0x77765,_0x24a308){return _0x77765-_0x24a308;}};if(_0x3d24aa[_0x4bacb4(0x24a)](currentQuestionIndex,0x0)){if(_0x3d24aa[_0x4bacb4(0x12b)](_0x3d24aa[_0x4bacb4(0x308)],_0x3d24aa['fMBZn'])){if(questionStartTime){if(_0x3d24aa[_0x4bacb4(0x12b)](_0x3d24aa[_0x4bacb4(0x114)],_0x3d24aa[_0x4bacb4(0x11e)]))questionStates[currentQuestionIndex][_0x4bacb4(0x174)]+=_0x3d24aa['YDfnM'](Date[_0x4bacb4(0xc2)](),questionStartTime);else{const _0x58ae93=_0x390e46[_0x4bacb4(0x2c0)](_0x1a75f7,arguments);return _0x4317da=null,_0x58ae93;}}currentQuestionIndex--,_0x3d24aa[_0x4bacb4(0x18f)](displayQuestion),_0x3d24aa['OIYAP'](saveProgress);}else _0x3d24aa[_0x4bacb4(0x18f)](_0x4c3cff);}}function nextQuestion(){const _0x251b9c=_0x5ae343,_0x4d42e5={'AJkfD':_0x251b9c(0x1d5),'tWtaE':_0x251b9c(0xd0),'gnnzQ':function(_0x1d6d87,_0x15dd7e){return _0x1d6d87-_0x15dd7e;},'pjWUQ':function(_0x5eb169,_0x3cb596){return _0x5eb169<_0x3cb596;},'rhcYU':function(_0x2708ca,_0x371711){return _0x2708ca-_0x371711;},'bdnxV':function(_0x1d323e){return _0x1d323e();},'oYQds':function(_0x1340b8,_0x3859f6){return _0x1340b8===_0x3859f6;},'KfEZW':_0x251b9c(0x274),'gENKy':function(_0x266d2a,_0x26cdef){return _0x266d2a===_0x26cdef;},'wfGnR':'test','xKdsI':function(_0x22b959,_0x4647a1){return _0x22b959===_0x4647a1;},'fTCbc':_0x251b9c(0x223),'awYTc':function(_0x419984,_0x1575ae){return _0x419984(_0x1575ae);},'sYqnY':_0x251b9c(0x15c),'MZtRX':'aOEYC','OvFiS':function(_0x2d3aea){return _0x2d3aea();}};questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x4d42e5[_0x251b9c(0xf4)](Date[_0x251b9c(0xc2)](),questionStartTime));if(_0x4d42e5['pjWUQ'](currentQuestionIndex,_0x4d42e5[_0x251b9c(0x17b)](questionsData[_0x251b9c(0x18e)],0x1)))currentQuestionIndex++,_0x4d42e5[_0x251b9c(0x9c)](displayQuestion),_0x4d42e5[_0x251b9c(0x9c)](saveProgress);else{if(_0x4d42e5['oYQds'](_0x4d42e5['KfEZW'],_0x4d42e5[_0x251b9c(0x33e)])){if(_0x4d42e5[_0x251b9c(0x281)](currentMode,_0x4d42e5[_0x251b9c(0x193)])||_0x4d42e5[_0x251b9c(0x26b)](currentMode,_0x4d42e5[_0x251b9c(0x30e)]))_0x4d42e5['awYTc'](confirm,_0x251b9c(0xfe))&&submitQuiz();else{if(confirm(_0x4d42e5[_0x251b9c(0x1b9)])){if(_0x4d42e5['MZtRX']===_0x4d42e5[_0x251b9c(0x201)])currentQuestionIndex=0x0,displayQuestion(),_0x4d42e5[_0x251b9c(0x158)](saveProgress);else{const _0x3dc742=_0x48ae74[_0x251b9c(0x1a3)](_0x53bec9[_0x251b9c(0x2e0)](_0x4d42e5[_0x251b9c(0x1f6)]))||{},_0x247bb2=_0x30f2a2[_0x251b9c(0x18e)],_0xf2f1fe=_0x488613['correctAnswers']||0x0;_0x3dc742[_0x291f3c]={'score':_0xf2f1fe,'total':_0x247bb2,'status':_0x4d42e5['tWtaE'],'completedOn':new _0xd97529()[_0x251b9c(0x178)]()},_0x4adf7a[_0x251b9c(0x203)]('userHistory',_0x669834['stringify'](_0x3dc742));}}}}else{if(_0xc2d8fc)_0x3e6f39+=_0x251b9c(0x1bd)+_0x572b67+_0x251b9c(0x1c6);}}}function startTimer(){const _0x85c3fa=_0x5ae343,_0x362419={'prDUo':_0x85c3fa(0x1fd),'ATzKC':'miEOK','bWMhg':function(_0x4693b5,_0x59ae7a){return _0x4693b5===_0x59ae7a;},'jnrBy':'timed_exam','ytbiU':function(_0x12000a){return _0x12000a();},'znHLJ':function(_0x25af69,_0x2784be){return _0x25af69(_0x2784be);},'AlMEl':function(_0x4b25dd,_0x35ae2d,_0x5d32dd){return _0x4b25dd(_0x35ae2d,_0x5d32dd);}};if(timer)_0x362419[_0x85c3fa(0x149)](clearInterval,timer);timeRemaining=0x78,updateTimerDisplay(),timer=_0x362419['AlMEl'](setInterval,()=>{const _0x4eef53=_0x85c3fa;timeRemaining--,updateTimerDisplay(),timeRemaining<=0x0&&(_0x362419[_0x4eef53(0x2c2)]!==_0x362419[_0x4eef53(0x22f)]?(clearInterval(timer),_0x362419[_0x4eef53(0xe3)](currentMode,_0x362419[_0x4eef53(0x2d7)])?_0x362419[_0x4eef53(0x221)](submitQuiz):_0x362419['ytbiU'](nextQuestion)):_0x3e10ba());},0x3e8);}function updateTimerDisplay(){const _0x38cc80=_0x5ae343,_0x2b38c6={'wbcvK':function(_0x5f23aa,_0x32b381){return _0x5f23aa/_0x32b381;},'vvrZj':function(_0x3cf463,_0x519751){return _0x3cf463%_0x519751;},'JsAkd':function(_0x239457,_0xf8e13c){return _0x239457+_0xf8e13c;}},_0x2e378c=Math[_0x38cc80(0xa5)](_0x2b38c6['wbcvK'](timeRemaining,0x3c)),_0x57c493=_0x2b38c6[_0x38cc80(0x1d0)](timeRemaining,0x3c);document[_0x38cc80(0x106)]('timeDisplay')[_0x38cc80(0x84)]=_0x2b38c6[_0x38cc80(0x23a)](_0x2e378c+':',_0x57c493[_0x38cc80(0x92)]()['padStart'](0x2,'0'));}function toggleSidebar(){const _0x3164ab=_0x5ae343,_0x39782a={'qGiOb':_0x3164ab(0x24c)};document[_0x3164ab(0x106)](_0x39782a[_0x3164ab(0xc5)])['classList'][_0x3164ab(0x1b0)](_0x3164ab(0x96));}document['addEventListener'](_0x5ae343(0x18b),()=>{const _0x1be26d=_0x5ae343,_0x50cfe4={'CegHz':_0x1be26d(0x1ea),'pfYiP':function(_0x85cf6d){return _0x85cf6d();},'JJJby':function(_0xe759ae,_0x3d827f){return _0xe759ae+_0x3d827f;},'rMldy':function(_0x3d6526,_0x2a16bd){return _0x3d6526===_0x2a16bd;},'PeaWJ':_0x1be26d(0x29c),'coXDd':'selected','FLVgG':function(_0x210519,_0x5a7f1d){return _0x210519+_0x5a7f1d;},'mhShU':_0x1be26d(0x211),'FsPDA':function(_0x5b2f36,_0x29e431){return _0x5b2f36+_0x29e431;},'BlLCn':_0x1be26d(0x250),'pVytg':'modeModal','zNjhh':'none','sFIcG':function(_0x336a1c,_0x4b5782){return _0x336a1c!==_0x4b5782;},'Fyivh':'edHwF','MOoDI':function(_0x1a62a5){return _0x1a62a5();},'Brmzt':_0x1be26d(0xdd),'DSRiB':_0x1be26d(0x257),'VeKpd':'YKMUs'};if(resume)loadProgress()?_0x50cfe4['BlLCn']===_0x50cfe4[_0x1be26d(0x177)]?(document[_0x1be26d(0x106)](_0x50cfe4['pVytg'])[_0x1be26d(0xf3)][_0x1be26d(0x29b)]=_0x50cfe4[_0x1be26d(0x1d3)],_0x50cfe4['pfYiP'](initializeQuiz)):_0x435e02[_0x1be26d(0xb9)](_0x50cfe4[_0x1be26d(0x111)]):_0x50cfe4[_0x1be26d(0x162)](_0x1be26d(0x320),_0x50cfe4[_0x1be26d(0x343)])?(_0x50cfe4['MOoDI'](clearProgress),document[_0x1be26d(0x106)](_0x50cfe4[_0x1be26d(0x12a)])[_0x1be26d(0xf3)]['display']=_0x50cfe4['Brmzt']):_0x50cfe4[_0x1be26d(0x271)](_0x3ebcbf);else{if(!window[_0x1be26d(0x1be)][_0x1be26d(0x30b)][_0x1be26d(0x1a2)](_0x50cfe4[_0x1be26d(0x28b)]))_0x50cfe4[_0x1be26d(0x1cf)](clearProgress),document['getElementById'](_0x50cfe4[_0x1be26d(0x12a)])[_0x1be26d(0xf3)]['display']=_0x1be26d(0xdd);else{if(_0x50cfe4[_0x1be26d(0x162)](_0x50cfe4[_0x1be26d(0x19d)],_0x1be26d(0x2f0))){const _0x1f4576=_0x1861ff[_0x1be26d(0x313)](_0x50cfe4[_0x1be26d(0x180)](0x41,_0x4c2506)),_0x27ce3b=_0x50cfe4[_0x1be26d(0x15f)](_0x141e4a,_0x18e690),_0x1a93a2=_0x4d3e1b[_0x1be26d(0x14b)](_0x50cfe4[_0x1be26d(0x8c)]);_0x1a93a2['innerHTML']='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x27ce3b?_0x50cfe4['coXDd']:'')+'\x22\x20data-option-index=\x22'+_0x65fda0+_0x1be26d(0x2cc)+_0x1f4576+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x5102bf[_0x1be26d(0x1c7)]||_0x50cfe4['FLVgG'](_0x50cfe4[_0x1be26d(0xb0)],_0x50cfe4[_0x1be26d(0x19a)](_0x464cf3,0x1)))+_0x1be26d(0x266),_0x2a8c8d['appendChild'](_0x1a93a2);}else initializeQuiz();}}}),document['addEventListener'](_0x5ae343(0xe1),function(_0x57ace0){const _0x1a6a3f=_0x5ae343,_0x4b1700={'lzzUb':function(_0x91dfbf){return _0x91dfbf();},'mqcJt':function(_0x5e3fcc,_0x4a39ef){return _0x5e3fcc!==_0x4a39ef;},'YEQYe':'none','LLMLD':_0x1a6a3f(0x10d),'dIltV':_0x1a6a3f(0x1e2),'Azyfx':function(_0x1cab73,_0x4d51e6){return _0x1cab73>=_0x4d51e6;},'Dqdnc':function(_0x427bd9,_0x1f69fe){return _0x427bd9(_0x1f69fe);},'gkXTW':_0x1a6a3f(0x202),'qcoHj':function(_0x260bda,_0x3c89d9){return _0x260bda<_0x3c89d9;},'KKpDQ':function(_0x3d70a5,_0x252477){return _0x3d70a5(_0x252477);},'qTyEk':_0x1a6a3f(0x11d),'gnTBE':function(_0x4c01e6){return _0x4c01e6();},'zLpjH':function(_0x5f2928,_0x1f2f60){return _0x5f2928===_0x1f2f60;},'iPyIA':'ArrowRight','fqaUt':function(_0x3c7c91,_0x2a7728){return _0x3c7c91===_0x2a7728;},'XkMZC':_0x1a6a3f(0x2d6),'oJIHc':_0x1a6a3f(0x1bf),'rCJwE':'GUYqt','kKpWR':function(_0x31f80f){return _0x31f80f();},'QfccB':function(_0x184585,_0x529eb8){return _0x184585===_0x529eb8;},'djcEs':function(_0x193ce2,_0x496f22){return _0x193ce2===_0x496f22;},'QeZVC':'timed_exam'};if(_0x4b1700[_0x1a6a3f(0x1b2)](document[_0x1a6a3f(0x106)]('modeModal')[_0x1a6a3f(0xf3)][_0x1a6a3f(0x29b)],_0x4b1700[_0x1a6a3f(0x218)]))return;if(document[_0x1a6a3f(0x106)](_0x4b1700[_0x1a6a3f(0x25c)])[_0x1a6a3f(0x27a)][_0x1a6a3f(0x293)](_0x4b1700[_0x1a6a3f(0x32f)])===![])return;if(_0x4b1700['Azyfx'](_0x57ace0['key'],'1')&&_0x57ace0['key']<='4'){const _0x4ba9b6=_0x4b1700[_0x1a6a3f(0x2c5)](parseInt,_0x57ace0['key'])-0x1,_0xf3c019=document[_0x1a6a3f(0x1ee)](_0x4b1700[_0x1a6a3f(0x321)]);if(_0x4b1700['qcoHj'](_0x4ba9b6,_0xf3c019[_0x1a6a3f(0x18e)]))_0x4b1700[_0x1a6a3f(0x1e1)](selectOption,_0x4ba9b6);}else{if(_0x57ace0[_0x1a6a3f(0x13f)]===_0x4b1700[_0x1a6a3f(0x15e)])_0x1a6a3f(0x33b)==='BPuWc'?(_0xaaf99a[_0x56a563]['status']=_0x1a6a3f(0x2ba),_0xfd4d3c[_0x1a6a3f(0x255)]++,_0x1d1cac[_0x1a6a3f(0x31e)]--):_0x4b1700[_0x1a6a3f(0x30a)](previousQuestion);else{if(_0x4b1700[_0x1a6a3f(0x2b2)](_0x57ace0[_0x1a6a3f(0x13f)],_0x4b1700[_0x1a6a3f(0x282)])||_0x4b1700[_0x1a6a3f(0x2b2)](_0x57ace0[_0x1a6a3f(0x13f)],'\x20'))_0x57ace0[_0x1a6a3f(0x2f4)](),_0x4b1700[_0x1a6a3f(0x33a)](nextQuestion);else{if(_0x4b1700['zLpjH'](_0x57ace0[_0x1a6a3f(0x13f)][_0x1a6a3f(0x23d)](),'b')&&(_0x4b1700[_0x1a6a3f(0x2d1)](currentMode,_0x4b1700[_0x1a6a3f(0x2ab)])||currentMode===_0x4b1700[_0x1a6a3f(0x31c)]))_0x4b1700[_0x1a6a3f(0x2d1)](_0x1a6a3f(0x1cd),_0x4b1700['rCJwE'])?_0x4b1700[_0x1a6a3f(0x33a)](_0x4bff5e):_0x4b1700[_0x1a6a3f(0x1ed)](toggleBookmark);else{if(_0x4b1700[_0x1a6a3f(0x2ca)](_0x57ace0[_0x1a6a3f(0x13f)][_0x1a6a3f(0x23d)](),'m')&&(_0x4b1700[_0x1a6a3f(0x245)](currentMode,'test')||_0x4b1700[_0x1a6a3f(0x2b2)](currentMode,_0x4b1700[_0x1a6a3f(0x302)])))toggleMarkForReview();else _0x4b1700[_0x1a6a3f(0x2ca)](_0x57ace0[_0x1a6a3f(0x13f)][_0x1a6a3f(0x23d)](),'s')&&(currentMode===_0x1a6a3f(0x109)||_0x4b1700[_0x1a6a3f(0x2b2)](currentMode,_0x4b1700[_0x1a6a3f(0x302)]))&&_0x4b1700[_0x1a6a3f(0x1ed)](submitQuiz);}}}}});function _0x36c4(){const _0x1f4202=['userHistory','urSnE','notAttemptedResult','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','PMstZ','IIa','dataset','review-question\x20','1497000mgUmnr','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','https://dhmbxeygs57ff.cloudfront.net/uploads/de69baed8b1d41cdbb00c4d4e5c135e4x1279x2261.JPEG','LMWH\x20is\x20given\x20by\x20which\x20route?','KKpDQ','hidden','LMWH','wdxCg','Predominant\x20activity\x20of\x20low-molecular-weight\x20heparin\x20is\x20seen\x20against\x20which\x20clotting\x20factor?','TnmrK','resume','oMfHj','Saxagliptin','customQuizData','XufEp','MDMWG','kKpWR','querySelectorAll','3.5\x20\x204.5','nOorE','ofCbX','ZeqHU','Which\x20of\x20the\x20following\x20drugs\x20is\x20under\x20clinical\x20trials\x20and\x20shows\x20a\x20reversal\x20in\x20the\x20action\x20of\x20all\x20direct\x20anticoagulants?','innerHTML','<p\x20style=\x22text-align:\x20justify;\x22>Since\x20<strong>no\x20effect</strong>&nbsp;was\x20noted\x20with\x20<strong>protamine\x20sulfate</strong>,\x20the\x20likely\x20anticoagulant\x20in\x20use\x20must\x20be\x20<strong>fondaparinux</strong>.<strong>&nbsp;</strong>This\x20is\x20because&nbsp;protamine\x20sulfate\x20<strong>fails\x20to\x20bind</strong>\x20the\x20drug.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Protamine\x20sulfate\x20binds\x20tightly\x20to\x20<strong>heparin</strong>\x20and\x20<strong>neutralizes</strong>\x20its\x20anticoagulant\x20effect.\x20It&nbsp;<strong>partially\x20reverses</strong>\x20the\x20anticoagulant\x20activity\x20of\x20<strong>LMWH</strong>&nbsp;also.\x20But\x20it\x20has\x20no\x20effect\x20on\x20fondaparinux.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>There\x20is\x20<strong>no\x20known\x20specific\x20antidote</strong>\x20approved\x20for\x20use\x20in\x20fondaparinux\x20overdose.\x20Fondaparinux-associated\x20bleeding\x20complications\x20are\x20managed\x20by\x20treatment\x20discontinuation\x20and\x20search\x20for\x20the\x20primary\x20cause.\x20Surgical\x20hemostasis,\x20blood\x20replacements,\x20fresh\x20plasma\x20transfusion,\x20plasmapheresis\x20should\x20be\x20considered.</p>','AJkfD','PmWRd','Factor\x20XII','Mark\x20for\x20Review','obpno','border-gray-600','XcXXb','aYpHI','Dicumarol','zmpoe','Coagulation\x20profile\x20monitoring\x20is\x20needed\x20in\x20therapy\x20with\x20which\x20of\x20the\x20following\x20drugs?','MZtRX','.option-button','setItem','2019390nMDloN','<div\x20class=\x22mt-4\x22><img\x20src=\x22','questionNav','Factor\x20IX','currentQuestion','cahfs','eWFYC','LFLyq','bstYP','none','Intravenous','fkNrP','yeBWZ','Option\x20','Requires\x20more\x20frequent\x20laboratory\x20monitoring','constructor','Correct','hePsf','DkxtN','qUhtz','YEQYe','border-green-500','not-attempted','map','kKtBp','tPaSo','MOCvW','<p>Hypokalemia\x20is\x20least\x20likely\x20seen\x20in\x20this\x20patient\x20because\x20<strong>heparin-induced\x20hypoaldosteronism</strong>\x20causes\x20<strong>hyperkalemia</strong>.</p>\x0a<p><strong>aPTT\x20is\x20prolonged</strong>\x20in\x20heparin\x20therapy\x20and\x20is\x20used\x20to\x20<strong>monitor</strong>\x20its\x20anticoagulant\x20effect.</p>\x0a<p>The\x20other\x20side-effects\x20of\x20heparin\x20are\x20(OATH):</p>\x0a<p\x20style=\x22padding-left:\x2030px;\x22>O\x20-\x20<strong>O</strong>steoporosis</p>\x0a<p\x20style=\x22padding-left:\x2030px;\x22>A\x20-\x20<strong>A</strong>lopecia\x20(reversible)</p>\x0a<p\x20style=\x22padding-left:\x2030px;\x22>T\x20-\x20<strong>T</strong>hrombocytopenia\x20(Heparin-Induced\x20Thrombocytopenia\x20-\x20HIT)</p>\x0a<p\x20style=\x22padding-left:\x2030px;\x22>H\x20-\x20<strong>H</strong>emorrhage,\x20<strong>H</strong>yperkalemia</p>','JaNAW','ytbiU','appendChild','timed_exam','Intradermal','It\x20is\x20the\x20weakest\x20acid\x20found\x20in\x20the\x20body','pIMgk','.m3u8','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','For\x20the\x20action\x20of\x20heparin\x20as\x20an\x20anticoagulant,\x20availability\x20of\x20which\x20of\x20the\x20following\x20chemical\x20substances\x20is\x20mandatory?','mkUwn','kYjyf','XBCqy','KQaWl','hiGBL','ATzKC','TlAzX','No\x20solution\x20available.','kEtKB','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','Protein\x20S','xCnOG','The\x20oral\x20thrombin\x20inhibitor\x20which\x20can\x20be\x20used\x20for\x20prevention\x20of\x20stroke\x20in\x20patients\x20with\x20non-valvular\x20atrial\x20fibrillation\x20is?','progressBar','nav-btn-marked-review','adYvC','JsAkd','QdhBr','explanation_images','toLowerCase','pbuck','prototype','jCDkv','trace','__proto__','red','MUdsj','djcEs','Activation\x20of\x20antithrombin','TzjRp','Macrocephaly','gLpDN','UgPZB','exception','quizSidebar','Incorrect','A\x20patient\x20with\x20sustained\x20atrial\x20fibrillation\x20was\x20given\x20heparin\x20cover.\x20What\x20is\x20the\x20primary\x20mechanism\x20of\x20action\x20of\x20the\x20drug?','981kDJLej','unWXp','src','<p>Low-molecular-weight\x20heparin(<strong>LMWH</strong>)&nbsp;has\x20predominant\x20activity\x20against&nbsp;<strong>factor\x20Xa.\x20</strong></p>\x0a<p>LMWH\x20has\x20an\x20anti-factor\x20activity\x20against\x20<strong>both</strong>\x20Xa\x20and\x20IIa\x20with\x20a\x20<strong>greater</strong>\x20effect\x20on\x20Xa.&nbsp;\x20&nbsp;<strong>&nbsp;</strong></p>','add','cAypv','totalAttempted','SipCx','custom_quiz.html','It\x20can\x20lead\x20to\x20thrombocytopenia','BnXhQ','split','Is\x20absorbed\x20more\x20uniformly\x20when\x20given\x20subcutaneously','LLMLD','Direct\x20factor\x20Xa\x20inhibitor','Unfractionated\x20heparin','qIDoj','ljlVu','questionStates','attachMedia','filter','pSnNL','Pharmacology','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','udFvb','green','vhNfS','button','xKdsI','ATvnI','Rivaroxaban','Prothrombin\x20time','<p>Factor\x20VII\x20is\x20a\x20vitamin\x20K\x20dependant\x20clotting\x20factor.</p>\x0a<p>The\x20vitamin\x20K\x20dependent\x20factors:&nbsp;</p>\x0a<ul>\x0a<li>Clotting\x20factors:\x20Factors\x20II,\x20VII,\x20IX,\x20X</li>\x0a<li>Anticoagulant\x20factors:\x20Protein\x20C\x20and\x20Protein\x20S</li>\x0a</ul>','5|3|0|2|4|1','pfYiP','In\x20patients\x20with\x20indications\x20for\x20warfarin\x20usage,\x20what\x20is\x20the\x20recommended\x20range\x20of\x20INR\x20necessary\x20for\x20safe\x20administration\x20of\x20the\x20drug?','</span><span>','ChgdS','Amiodarone','PwfuF','oyFdK','nav-btn-bookmarked','Vitamin\x20K\x20epoxide\x20reductase','classList','60-anticoagulants-9b94cc9b.html','OryVw','dhMQw','question_video','OWBSO','<p\x20style=\x22text-align:\x20justify;\x22>Macrocephaly\x20is\x20not\x20a\x20fetal\x20abnormality\x20caused&nbsp;by\x20warfarin\x20administered\x20during\x20pregnancy.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22><strong>Warfarin\x20crosses\x20the\x20placenta</strong>\x20and\x20can\x20cause\x20fetal\x20abnormalities\x20which\x20include\x20<strong>nasal\x20hypoplasia</strong>\x20and\x20<strong>stippled\x20epiphyses</strong>\x20leading\x20to\x20abnormal\x20bone\x20formation.\x20<strong>Fetal\x20or\x20neonatal\x20hemorrhage</strong>\x20is\x20also\x20seen.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>The\x20risk\x20of\x20embryopathy\x20is\x20<strong>highest</strong>\x20with\x20exposure\x20in\x20the\x20<strong>first\x20trimester</strong>\x20of\x20pregnancy.\x20<strong>CNS\x20abnormalities</strong>\x20have\x20also\x20been\x20reported\x20following\x20exposure\x20during\x20the\x20<strong>second\x20and\x20third\x20trimesters</strong>.&nbsp;</p>','gENKy','iPyIA','fQacy','jHEQt','Irxte','JLsBn','UGHsF','Low\x20molecular\x20weight\x20heparins\x20should\x20be\x20avoided','Previous\x20progress\x20cleared.','ArKUJ','DSRiB','fzSWk','currentMode','In\x20a\x20patient\x20receiving\x20warfarin\x20tablets,\x20which\x20enzyme\x20primarily\x20metabolizes\x20the\x20drug?','Thrombomodulin','A\x20patient\x20with\x20a\x20history\x20of\x20regular\x20oral\x20anticoagulant\x20therapy\x20suffers\x20a\x20traumatic\x20injury.\x20He\x20receives\x20idarucizumab\x20before\x20damage\x20control\x20surgery\x20to\x20reverse\x20the\x20anticoagulant\x20effect.\x20Identify\x20the\x20oral\x20anticoagulant\x20that\x20was\x20being\x20used\x20by\x20the\x20patient.','bMHnI','Hepatic\x20impairment','contains','gMJYL','jxwdf','DXwTF','markReviewText','Prolonged\x20aPTT','While\x20prescribing\x20warfarin,\x20a\x20decreased\x20effect\x20of\x20the\x20drug\x20is\x20expected\x20in\x20patients\x20with\x20which\x20of\x20the\x20following\x20conditions?','iUfgY','display','div','Stippled\x20epiphyses','Apixaban\x20belongs\x20to\x20which\x20of\x20the\x20following\x20class\x20of\x20drugs?','return\x20(function()\x20','className','EAXPg','Fondaparinux','block','qFkSE','\x20-\x20Brain\x20And\x20Scalpel','NsqHX','A\x2064-year-old\x20man\x20was\x20started\x20on\x20heparin\x20postoperatively\x20for\x20thromboprophylaxis.\x20After\x20a\x20week\x20he\x20developed\x20sudden\x20difficulty\x20in\x20breathing.\x20His\x20platelet\x20count\x20was\x20found\x20to\x20be\x2070,000/microliter.\x20Which\x20of\x20the\x20following\x20is\x20incorrect\x20regarding\x20the\x20management\x20of\x20this\x20patient?','ECgJK','euQUw','hAIpY','XkMZC','ziGQd','<p>The\x20anticoagulant\x20of\x20choice\x20for\x20the\x20management\x20of<strong>\x20cancer-associated\x20thromboembolism</strong>\x20is\x20<strong>l</strong><strong>ow-molecular-weight\x20heparin\x20</strong>(LMWH).</p>\x0a<p>It\x20is\x20the\x20preferred\x20agent\x20because\x20of\x20more\x20bioavailability,\x20lack\x20of\x20need\x20for\x20anticoagulant\x20monitoring,\x20and\x20a\x20long\x20t1/2.&nbsp;</p>\x0a<p>Venous\x20thromboembolism\x20(including\x20deep\x20vein\x20thrombosis,\x20pulmonary\x20embolism,\x20and\x20splanchnic\x20vein\x20thrombosis),\x20is\x20a\x20frequent\x20complication\x20of\x20cancer\x20and\x20is\x20the\x20second-leading\x20cause\x20of\x20death\x20in\x20cancer\x20patients\x20receiving\x20chemotherapy.</p>\x0a<p>Based\x20on\x20the\x20results\x20from\x20the&nbsp;<strong>C</strong>omparison\x20of\x20<strong>L</strong>ow-molecular-weight&nbsp;heparin\x20vs.&nbsp;<strong>O</strong>ral\x20anticoagulants\x20for\x20long-term\x20anticoagulation\x20in\x20cancer\x20patients\x20with\x20venous\x20<strong>T</strong>hromboembolism\x20(<strong>CLOT</strong>)\x20Trial,\x20all\x20recent\x20guidelines\x20now\x20advise\x20LMWH\x20for\x20cancer-associated\x20thromboembolism.&nbsp;</p>\x0a<p>However,\x20unfractionated\x20heparin\x20<strong>(UFH)</strong>\x20can\x20be\x20used\x20in\x20patients\x20with\x20<strong>renal\x20failure</strong>,\x20and\x20<strong>fondaparinux</strong>\x20can\x20be\x20considered\x20in\x20patients\x20with\x20heparin-induced\x20thrombocytopenia\x20(<strong>HIT</strong>).</p>','<p\x20style=\x22text-align:\x20justify;\x22>The\x20most\x20common\x20presentation\x20of\x20heparin-induced\x20thrombocytopenia\x20is\x20<strong>venous\x20thrombosis</strong>.</p>\x0a<p>HIT\x20is\x20an\x20immune\x20complication\x20of\x20heparin\x20therapy\x20caused\x20by\x20<strong>IgG</strong>&nbsp;<strong>antibodies\x20</strong>against\x20the<strong>\x20heparin-platelet\x20factor\x204\x20complex</strong>.\x20This\x20results\x20in\x20the\x20activation\x20of\x20platelets\x20to\x20propagate\x20a\x20hypercoagulable\x20state\x20culminating\x20in\x20life-threatening\x20thrombosis.&nbsp;</p>\x0a<p>It\x20is\x20characterized\x20by&nbsp;<strong>thrombocytopenia</strong>&nbsp;(Platelet\x20count\x20&lt;1,00,000/&mu;L\x20or\x20reduced\x20by\x20over\x2050%\x20from\x20pre-treatment\x20value)\x20and\x20clinically\x20presents\x20as&nbsp;<strong>v</strong><strong>enous\x20thrombosis</strong>&nbsp;(in\x20the\x20form\x20of&nbsp;<strong>DVT</strong>&nbsp;or&nbsp;<strong>pulmonary\x20embolism</strong>)</p>\x0a<p>It\x20occurs\x20around&nbsp;<strong>5-10\x20days</strong>&nbsp;after\x20starting\x20heparin.\x20It\x20is\x20more\x20common\x20with\x20UFH\x20when\x20compared\x20to\x20LMWH.\x20It\x20is\x20also\x20more\x20common\x20in\x20women\x20surgical\x20patients.&nbsp;Arterial\x20thrombosis\x20(resulting\x20in\x20MI\x20or\x20stroke),\x20as\x20well\x20as\x20bilateral\x20adrenal\x20hemorrhage,\x20can\x20rarely\x20occur.</p>','KScyH','1.0\x20\x201.5','selected','zLpjH','closest','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','MnIwa','lRbyT','\x20>\x20','aSEbh','eeUPe','answered','TYvJw','Direct\x20thrombin\x20inhibitor','okNMS','<p>Immediate\x20or\x20urgent\x20reversal\x20of\x20<strong>warfarin-induced\x20bleeding</strong>\x20is\x20best\x20achieved\x20by\x20the\x20administration\x20of\x20<strong>prothrombin\x20complex\x20concentrates</strong>\x20(PCC).</p>\x0a<p>These\x20are\x20highly\x20purified\x20concentrates\x20prepared\x20from\x20pooled\x20plasma\x20and\x20contain&nbsp;<strong>factors\x20II,\x20IX,\x20and\x20X</strong>.\x20Factor\x20VII\x20may\x20be\x20included\x20or\x20produced\x20separately.</p>\x0a<p>Option\x20D<strong>:\x20Vitamin\x20K1</strong>&nbsp;is\x20the\x20specific\x20antidote\x20for\x20warfarin-induced\x20bleeding,\x20but\x20it\x20<strong>takes\x206-24\x20hours</strong>\x20for\x20the\x20clotting\x20factors\x20to\x20be\x20resynthesized\x20and\x20released\x20in\x20blood\x20after\x20Vitamin\x20K\x20administration\x20and\x20hence\x20its\x20action\x20is\x20delayed\x20for\x20several\x20hours.&nbsp;&nbsp;</p>\x0a<p>Option\x20A:\x20Cryoprecipitate\x20mainly\x20contains\x20factor\x20VIII\x20and\x20fibrinogen\x20and\x20therefore\x20is\x20not\x20suitable\x20for\x20warfarin-induced\x20bleeding,\x20as\x20warfarin\x20inhibits\x20factors\x20II,&nbsp;VII,&nbsp;IX,\x20X.</p>\x0a<p>Option\x20B:\x20Fresh\x20frozen\x20plasma\x20can\x20also\x20be\x20used\x20but\x20prothrombin\x20complex\x20concentrate\x20normalizes\x20the\x20INR\x20more\x20rapidly.</p>','uIlzN','apply','LbqUA','prDUo','VQrKU','Protamine\x20sulfate','Dqdnc','yDgnL','Enoxaparin','puivB','stringify','QfccB','NFLlL','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','60\x20Anticoagulants','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','SbCWR','fqaUt','A\x2065-year-old\x20patient\x20has\x20been\x20scheduled\x20for\x20cardiopulmonary\x20bypass\x20surgery.\x20Which\x20is\x20the\x20anticoagulant\x20of\x20choice\x20for\x20this\x20patient?','prvsz','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','click','study','jnrBy','Lepirudin','<p>The\x20FDA\x20recently\x20approved\x20the\x20drug\u00a0Apixaban\x20for\x20a\x20new\x20indication.\x20The\x20drug\x20is\x20now\x20used\x20to\x20reduce\x20the\x20risk\x20of\x20stroke\x20and\x20systemic\x20embolism\x20in\x20patients\x20with\x20nonvalvular\x20atrial\x20fibrillation.</p>','2.0\x20\x203.0','<p><strong>Warfarin</strong>&nbsp;is\x20primarily\x20metabolized\x20by\x20<strong>CYP2C9</strong>.</p>\x0a<p>Genetic\x20polymorphisms\x20of\x20CYP2C9\x20and\x20drugs\x20inhibiting\x20or\x20inducing\x20CYP2C9\x20can\x20result\x20in\x20variable\x20response\x20to\x20warfarin\x20administration.</p>','Ciraparantag','iCsEe','vptee','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','getItem','MCRVk','QOISk','push','EFHzE','ytYiZ','MyVcZ','bind','Factor\x20VII','accuracy','Andexanet\x20alfa','UzNaU','YYidT','FXBUx','BJeKd','Unfractionated\x20Heparin','YKMUs','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','Heparin','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','preventDefault','TbgqJ','<p\x20class=\x22p1\x22>Idarucizumab\x20is\x20a\x20reversal\x20agent\x20for&nbsp;<strong>dabigatran</strong>.\x20It\x20is\x20a\x20humanized\x20mouse\x20<strong>monoclonal\x20antibody</strong>\x20fragment.</p>\x0a<p\x20class=\x22p1\x22>It\x20binds\x20<strong>irreversibly</strong>\x20to&nbsp;dabigatran\x20and\x20forms\x20a\x20complex\x20that\x20is\x20<strong>cleared\x20by\x20the\x20kidneys</strong>.</p>','Thrombocytopenia','Warfarin','IUXIm','gwdAM','uyOAN','incomplete','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','Which\x20among\x20the\x20following\x20is\x20not\x20a\x20fetal\x20abnormality\x20expected\x20after\x20warfarin\x20administration\x20to\x20a\x20pregnant\x20patient?','xZTxt','sWeVb','QeZVC','YFYwz','Venous\x20thrombosis','Factor\x20I','isArray','kCian','MJVTy','SUdBo','gnTBE','pathname','solutionContainer','zjGnZ','fTCbc','questionReviewSection','QXMZa','optionsContainer','totalTime','fromCharCode','<p\x20style=\x22text-align:\x20justify;\x22><strong>Protamine\x20sulfate\x20</strong>is\x20the\x20drug\x20used\x20to\x20treat\x20life-threatening,\x20<strong>heparin-induced\x20bleeding</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20a\x20mixture\x20of\x20basic\x20polypeptides\x20isolated\x20from\x20<strong>salmon\x20sperm</strong>.&nbsp;It\x20binds\x20to\x20acidic\x20heparin\x20with\x20high\x20affinity\x20and\x20neutralizes\x20anticoagulant\x20activity.\x20The\x20resultant\x20protamine-heparin\x20complexes\x20are\x20cleared.\x20Protamine\x20binds\x20only\x20to\x20<strong>long\x20heparin\x20</strong>molecules\x20(UFH).\x20Therefore,\x20protamine\x20only\x20<strong>partially\x20reverses</strong>&nbsp;the\x20activity\x20of\x20<strong>LMWH</strong>\x20and\x20has\x20<strong>no\x20effect</strong>\x20on&nbsp;<strong>fondaparinux</strong>.&nbsp;</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20most\x20commonly\x20used\x20to\x20neutralize\x20heparin-induced\x20anticoagulation\x20after\x20separation\x20from\x20cardiopulmonary\x20bypass.\x20It\x20is\x20also\x20utilized\x20in\x20the\x20setting\x20of\x20dialysis,\x20invasive\x20vascular\x20procedures,\x20and\x20acute\x20ischemic\x20strokes.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>Note:\x20Protamine\x20sulfate\x20has<strong>\x20anticoagulant\x20activity</strong>\x20at\x20<strong>higher\x20doses</strong>\x20and\x20hence,\x20only\x20small\x20amounts\x20of\x20protamine\x20(1mg/100\x20units\x20of\x20heparin)\x20are\x20used\x20for\x20heparin-induced\x20bleeding.</p>','referrer','get','VJtXn','round','wqDXt','Congestive\x20heart\x20failure','Nephrotic\x20syndrome','oJIHc','VADdz','notAttempted','CYP2C9','mdeMQ','gkXTW','JUEmz','log','canPlayType','Life-threatening\x20bleeding\x20in\x20a\x20patient\x20receiving\x20heparin\x20is\x20treated\x20immediately\x20with\x20a\x20drug\x20X\x20that\x20reverses\x20its\x20effects.\x20Identify\x20the\x20type\x20of\x20antagonism\x20between\x20X\x20and\x20heparin.','UKAKW','Which\x20is\x20the\x20anticoagulant\x20of\x20choice\x20for\x20the\x20management\x20of\x20cancer-associated\x20thromboembolism?','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','A\x20patient\x20is\x20on\x20DVT\x20prophylaxis\x20with\x20warfarin.\x20It\x20has\x20an\x20inhibitory\x20action\x20on\x20which\x20of\x20the\x20following\x20enzymes?','gray','Hypokalemia','Bleeding\x20time','ckPac','prevBtn','dIltV','A\x20patient\x20suffering\x20from\x20non-valvular\x20atrial\x20fibrillation\x20is\x20prescribed\x20warfarin\x20tablets.\x20Which\x20of\x20the\x20following\x20clotting\x20factors\x20would\x20you\x20expect\x20to\x20decline\x20the\x20earliest\x20in\x20this\x20patient\x20after\x20drug\x20administration?','EMtKb','COYGT','dhtZe','cpcnB','\x22\x20data-src=\x22','Chemical','iFkBC','QPUrP','YVMPz','lzzUb','LUFyB','Argatroban','zbtAv','KfEZW','join','submitSection','lCAIt','<p><strong>Ciraparantag</strong>\x20is\x20a\x20synthetic\x20cationic\x20molecule\x20that\x20binds\x20to\x20all\x20direct\x20anticoagulants\x20(dabigatran\x20and\x20other\x20oral\x20factor\x20Xa\x20inhibitors)\x20as\x20well\x20as\x20heparin\x20and\x20LMWH\x20and\x20reverses\x20their\x20actions.\x20It\x20is\x20still\x20<strong>under\x20trial</strong>.&nbsp;</p>\x0a<p>Option\x20A:\x20Protamine\x20sulfate\x20reverses\x20the\x20action\x20of\x20heparin\x20and\x20LMWH.</p>\x0a<p>Option\x20B:\x20Idarucizumab\x20is\x20a\x20specific\x20antidote\x20for\x20dabigatran\x20overdose.&nbsp;</p>\x0a<p>Option\x20C:\x20Andexanet\x20alfa\x20is\x20a\x20decoy\x20for\x20oral\x20factor\x20Xa\x20inhibitors.&nbsp;</p>','Fyivh','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','AbDWH','ZSpSR','SeXPG','padStart','hierarchy','textContent','target','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','Plasmin','nBeml','4|3|5|2|1|0','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','VEgDL','PeaWJ','MHrob','PQUvN','choices','zJNDd','Alternative\x20anticoagulant\x20such\x20as\x20argatroban\x20should\x20be\x20administered','toString','NxdBd','remove','status','open','Either\x20a\x20or\x20b','<p\x20style=\x22text-align:\x20justify;\x22>Decreased\x20effect\x20of\x20warfarin\x20is\x20seen\x20in\x20patients\x20with\x20<strong>nephrotic\x20syndrome</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Warfarin\x20is\x20<strong>highly\x20bound\x20to\x20plasma\x20protein</strong>\x20and\x20in\x20nephrotic\x20syndrome\x20there\x20is\x20proteinuria.\x20Drugs\x20that\x20are\x20bound\x20to\x20plasma\x20proteins\x20are\x20lost\x20in\x20the\x20urine.\x20Similarly,\x20<strong>warfarin\x20is\x20lost\x20in\x20urine</strong>\x20in\x20nephrotic\x20syndrome,\x20resulting\x20in\x20a\x20decreased\x20effect.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Option\x20C:\x20Warfarin&nbsp;is\x20mainly&nbsp;<strong>metabolized&nbsp;</strong>by\x20the<strong>&nbsp;CYP2C9</strong>&nbsp;enzyme.\x20In\x20patients\x20being\x20treated\x20with\x20metronidazole\x20(a\x20CYP2C9\x20inhibitor),\x20the\x20metabolism\x20of\x20warfarin\x20is\x20decreased.\x20Hence,\x20the\x20effect\x20of\x20warfarin\x20is\x20increased.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Options\x20B\x20and\x20D:\x20Hepatic\x20impairment,\x20congestive\x20heart\x20failure,\x20and\x20hyperthyroidism\x20lead\x20to\x20<strong>low\x20concentrations\x20of\x20clotting\x20factors</strong>\x20and\x20thus\x20the\x20effect\x20of\x20warfarin\x20is\x20enhanced\x20in\x20these\x20conditions.</p>','bookmarkText','<p>The\x20parenteral\x20direct\x20thrombin\x20inhibitor\x20is\x20<strong>argatroban</strong>.</p>\x0a<p>Argatroban\x20binds\x20reversibly\x20to\x20thrombin\x20and\x20inhibits\x20it.\x20It\x20is\x20metabolized\x20in\x20the\x20liver\x20and\x20excreted\x20in\x20bile,\x20so\x20it\x20can\x20be\x20<strong>safely\x20</strong>used\x20in\x20patients\x20with\x20<strong>renal\x20impairment</strong>.</p>\x0a<p>It\x20can\x20be\x20used\x20for\x20prophylaxis\x20and\x20treatment\x20of\x20<strong>heparin-induced\x20thrombocytopenia\x20(HIT)</strong>.</p>\x0a<p>Other\x20parenteral\x20direct\x20thrombin\x20inhibitors\x20are\x20their\x20indications:&nbsp;</p>\x0a<ul>\x0a<li>Lepirudin\x20-\x20was\x20indicated\x20in\x20HIT\x20but\x20is\x20discontinued\x20now</li>\x0a<li>Desirudin\x20-\x20indicated\x20for\x20thromboprophylaxis\x20in\x20hip\x20replacement\x20surgery</li>\x0a<li>Bivalirudin\x20-\x20used\x20in\x20procedures\x20like\x20coronary\x20angioplasty\x20or\x20cardiopulmonary\x20bypass\x20surgery\x20and\x20HIT.&nbsp;</li>\x0a</ul>','VEfRZ','bdnxV','</span></div>','tLPFx','eWWhx','navBtn_','Bleeding','QMiFa','Zcnup','EhKvr','floor','strokeDasharray','hnlkD','Factor\x20II','448PbPkIF','Factor\x20Xa\x20inhibitor','selectedAnswer','WefJP','sojOl','width','xysxS','mhShU','Isoniazid','timerContainer','<p><strong>Warfarin</strong>\x20directly\x20inhibits\x20the\x20enzyme\x20<strong>Vitamin\x20K\x20epoxide\x20reductase</strong>.</p>\x0a<p>It\x20inhibits\x20the\x20conversion\x20of\x20vitamin\x20K\x20epoxide\x20to\x20its\x20reduced\x20form\x20-\x20vitamin\x20K\x20hydroquinone\x20which&nbsp;is\x20a\x20<strong>co-factor</strong>\x20for\x20the\x20enzyme\x20<strong>gamma-glutamyl\x20carboxylase</strong>.\x20This\x20enzyme\x20catalyzes\x20the\x20&gamma;-carboxylation\x20process&nbsp;of\x20vitamin\x20K\x20dependent\x20clotting\x20factors.</p>','markReviewBtn','MZwMC','A\x20patient\x20with\x20splanchnic\x20vein\x20thrombosis\x20has\x20been\x20started\x20on\x20warfarin\x20therapy.\x20Which\x20of\x20the\x20following\x20can\x20be\x20used\x20to\x20monitor\x20the\x20treatment\x20in\x20this\x20patient?','Carbamazepine','mSSXU','removeItem','reload','totalQuestionsResult','correctAnswers','correct','strokeDashoffset','questions','quizPerformanceData','explanation_video','now','console','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','qGiOb','TnZaa','forEach','1702jxYBhG','addEventListener','dFqhQ','PBgxk','JLOtX','poZwP','accuracyScore','Activated\x20partial\x20thromboplastin\x20time','completed','Vznau','HErkO','explanation_audio_hin','questionIndex','<p\x20style=\x22text-align:\x20justify;\x22>The\x20patient\x20in\x20the\x20above\x20scenario\x20has\x20<strong>heparin-induced\x20thrombocytopenia\x20(HIT)</strong>.\x20Direct\x20thrombin\x20inhibitors,&nbsp;such\x20as\x20<strong>argatroban&nbsp;</strong>is\x20the\x20anticoagulant\x20of\x20choice\x20in\x20HIT.</p>\x0a<p>Management\x20of\x20HIT:</p>\x0a<ul\x20style=\x22text-align:\x20justify;\x22>\x0a<li\x20class=\x22p1\x22><strong>Stop</strong>\x20heparin/LMWH</li>\x0a<li\x20class=\x22p1\x22>Give\x20an\x20alternative\x20anticoagulant,\x20such\x20as\x20lepirudin,\x20<strong>argatroban</strong>,\x20bivalirudin,\x20<strong>fondaparinux</strong>\x20or\x20rivaroxaban</li>\x0a<li\x20class=\x22p1\x22>Do\x20not\x20give\x20platelet\x20transfusions\x20(it\x20only\x20worsens\x20the\x20consumptive\x20coagulopathy)</li>\x0a<li\x20class=\x22p1\x22><strong>Do\x20not\x20give\x20warfarin</strong>\x20until\x20the\x20platelet\x20count\x20returns\x20to\x20its\x20baseline\x20level.\x20If\x20warfarin\x20was\x20administered,\x20give\x20vitamin\x20K\x20to\x20restore\x20the\x20INR\x20to\x20normal.</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Increased\x20thrombin\x20generation\x20associated\x20with\x20HIT\x20can\x20cause\x20consumption\x20of\x20protein\x20C.\x20<strong>Warfarin</strong>\x20administration\x20can\x20<strong>further\x20decrease\x20protein\x20C\x20levels</strong>\x20and\x20cause\x20<strong>skin\x20necrosis</strong>.\x20Therefore\x20warfarin\x20is\x20avoided\x20in\x20HIT.</p>','Idarucizumab','NWoJY','xmmHm','xHrag','OlGXa','GGkcX','JXRgD','flex','correctCount','dQpQh','Cryoprecipitate','keydown','OQdpp','bWMhg','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','rdTSa','application/vnd.apple.mpegurl','questionText','280BZIJGU','sNJSy','Cimetidine','CoZDA','SKtDq','zneyD','testModeReviewLegend','diUhB','vPatM','totalQuestions','reduce','style','gnnzQ','studyModeLegend','Skin\x20necrosis','BMiRe','Heparin\x20should\x20be\x20replaced\x20with\x20warfarin','iHjxt','solutionText','AXGIm','DvGul','explanation_audio_eng','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','incorrect','totalTimeResult','As\x20compared\x20to\x20unfractionated\x20heparin,\x20which\x20of\x20the\x20following\x20is\x20true\x20about\x20enoxaparin?','pcvxd','Apixaban','Marked','AzVQo','getElementById','tZMSN','Tranexamic\x20acid','test','timeDisplay','gUJXd','Knoyj','performanceModal','Bookmarked','Lab\x20reports\x20of\x20a\x2045-year-old\x20female\x20patient,\x20who\x20was\x20recently\x20started\x20on\x20heparin,\x20showed\x20rapidly\x20falling\x20platelet\x20counts.\x20She\x20was\x20suspected\x20to\x20have\x20heparin-induced\x20thrombocytopenia.\x20What\x20is\x20the\x20most\x20common\x20presentation\x20seen\x20in\x20this\x20condition?','UWSso','CegHz','replace','xMZKu','nMzgB','search','fill','1|5|2|3|4|0','Competitive','ioiSx','onclick','ODxTI','joURn','ArrowLeft','CbRGa','includes','Dabigatran','Predisposes\x20to\x20a\x20higher\x20risk\x20of\x20osteopenia','pop','OLbvx','erQcN','IAMuh','zIccm','sxXmL','MghXU','hqOOB','pVytg','iDhrD','1486919RTqiCi','CYP1A2','Ywwmh','Bivalirudin','Vitamin\x20K1','Factor\x20X','baMNR','FjHJy','statsBar','Which\x20of\x20the\x20following\x20drugs\x20does\x20not\x20increase\x20the\x20risk\x20of\x20bleeding\x20in\x20patients\x20undergoing\x20warfarin\x20therapy?','ZawgX','reviewQuestionsContainer','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','XjBxm','Phenindione','vRkaT','<p\x20style=\x22text-align:\x20justify;\x22><strong>\x20Antithrombin-III</strong>\x20is\x20mandatory\x20for\x20the\x20action\x20of\x20heparin<strong>&nbsp;</strong>as\x20an\x20anticoagulant.\x20<strong>Reduced\x20antithrombin</strong>\x20levels\x20can\x20lead\x20to\x20<strong>resistance</strong>.</p>\x0a<div\x20class=\x22c-article-section__content\x22>\x0a<p><strong>Heparin\x20resistance\x20</strong>refers\x20to<strong>\x20failure\x20to&nbsp;</strong><strong>achieve\x20a\x20therapeutic\x20aPTT</strong>\x20with\x20daily\x20doses\x20of\x20heparin\x20of\x2035,000\x20units\x20or\x20more.</p>\x0a<p>In\x20true\x20heparin\x20resistance,\x20there\x20is\x20an\x20actual\x20blunting\x20of\x20heparin&rsquo;s\x20anticoagulant\x20effect.&nbsp;This\x20occurs\x20due\x20to:</p>\x0a<ul>\x0a<li><strong>Low\x20ATIII\x20</strong>levels\x20(most\x20common\x20cause)</li>\x0a<li>Increased\x20heparin-binding\x20plasma\x20proteins\x20(acute\x20phase\x20reactants)</li>\x0a<li>Increased\x20heparin\x20clearance\x20(e.g.\x20due\x20to\x20splenomegaly\x20in\x20liver\x20disease)</li>\x0a</ul>\x0a</div>\x0a<div\x20class=\x22c-article-section__content\x22>\x0a<p>Low\x20ATIII\x20levels\x20could\x20be\x20due\x20to\x20decreased\x20synthesis\x20(hereditary,\x20hepatic\x20failure),\x20increased\x20consumption\x20(DIC,\x20MAHA,\x20or\x20in\x20a\x20bypass\x20circuit)\x20or\x20increased\x20loss\x20(nephrotic\x20syndrome).</p>\x0a<p>The\x20<strong>dose\x20of\x20heparin\x20has\x20to\x20be\x20increased</strong>\x20to\x20achieve\x20therapeutic&nbsp;aPTT.\x20Severe\x20antithrombin\x20deficiency\x20may\x20require\x20antithrombin\x20concentrate\x20as\x20well.</p>\x0a</div>','not_attempted','correct_choice_id','key','NAiAt','loadSource','GmPQu','<p><strong>Rivaroxaban\x20</strong>is\x20an<strong>&nbsp;oral\x20direct\x20factor\x20Xa\x20inhibitor.</strong>&nbsp;They\x20represent\x20a\x20new\x20class\x20of\x20oral\x20anticoagulant\x20drugs\x20that\x20<strong>do\x20not\x20require\x20monitoring</strong>.</p>\x0a<p>This\x20group\x20of\x20drugs\x20inhibit\x20factor\x20Xa\x20in\x20the\x20final\x20common\x20pathway\x20of\x20clotting\x20[conversion\x20of\x20Prothrombin\x20(Factor\x20II)\x20to\x20thrombin\x20(Factor\x20IIa)].\x20They\x20are\x20given\x20as\x20fixed\x20doses\x20and\x20have\x20a\x20rapid\x20onset\x20of\x20action.</p>\x0a<p>Oral\x20direct\x20factor\x20Xa\x20inhibitors\x20are\x20<strong>indicated</strong>\x20in:</p>\x0a<ul>\x0a<li>Prevention\x20of\x20embolic\x20stroke\x20in\x20patients\x20with\x20atrial\x20fibrillation\x20(without\x20valvular\x20heart\x20disease)</li>\x0a<li>Venous\x20thromboembolic\x20disease\x20(VTE)</li>\x0a<li>Postoperative\x20thromboprophylaxis\x20in\x20patients\x20undergoing\x20hip\x20and\x20knee\x20arthroplasty</li>\x0a</ul>','kLjUi','nlBVV','solution','pfAsT','iEfKA','znHLJ','ahZxP','createElement','26704UwPMNY','<p>The\x20clinical\x20features\x20and\x20the\x20image\x20given\x20are\x20suggestive\x20of\x20<strong>warfarin-induced\x20skin\x20necrosis</strong>\x20seen\x20due\x20to\x20a\x20congenital\x20or\x20acquired\x20deficiency\x20in\x20either<strong>\x20protein\x20C\x20or\x20protein\x20S.</strong></p>\x0a<p>Warfarin\x20therapy\x20in\x20such\x20patients\x20leads\x20to\x20a\x20rapid\x20fall\x20in&nbsp;protein\x20C\x20or\x20protein\x20S,\x20which\x20are\x20<strong>vitamin\x20K\x20dependent\x20anticoagulants</strong>.\x20This\x20occurs\x20before\x20warfarin\x20can\x20exert\x20an\x20antithrombotic\x20effect.</p>\x0a<p\x20class=\x22p1\x22>Treatment:\x20Warfarin\x20should\x20be\x20discontinued\x20and\x20vitamin\x20K\x20(the\x20antidote\x20for\x20warfarin)\x20should\x20be\x20administered.</p>','DONmW','It\x20is\x20commonly\x20obtained\x20from\x20pig\x20intestine','RgRpu','index.html','bookmarkedQuestions','eBArK','KbNLN','vcNLm','dFdTc','bTpql','OvFiS','1172500goDErf','Nasal\x20hypoplasia','Dornase\x20alfa','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','Fondaparinux\x20can\x20be\x20best\x20described\x20as\x20which\x20of\x20the\x20following?','qTyEk','rMldy','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','question_audio','sFIcG','question_images','HulmE','<p\x20style=\x22text-align:\x20justify;\x22><strong>Warfarin\x20therapy\x20</strong>is\x20usually\x20<strong>monitored</strong>\x20by\x20measuring\x20<strong>prothrombin\x20time.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Prothrombin\x20time\x20is\x20sensitive\x20to\x20the\x20reduction\x20in\x20levels\x20of\x20<strong>prothrombin,\x20factor\x20VII,\x20and\x20factor\x20X</strong>.\x20The\x20test\x20is\x20performed\x20by\x20adding\x20thromboplastin,\x20which\x20is\x20a\x20reagent\x20containing\x20tissue\x20factor,\x20phospholipid\x20and\x20calcium\x20to\x20citrated\x20plasma\x20and\x20determining\x20the\x20time\x20to\x20clot\x20formation.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Due\x20to\x20the\x20variable\x20sensitivity\x20of\x20thromboplastin,\x20the\x20<strong>International\x20normalized\x20ratio\x20(INR)</strong>\x20was\x20developed\x20to\x20standardize\x20the\x20reporting\x20of\x20prothrombin\x20time.\x20In\x20INR,\x20the\x20patient&rsquo;s\x20prothrombin\x20time\x20is\x20divided\x20by\x20mean\x20normal\x20prothrombin\x20time\x20and\x20this\x20ratio\x20is\x20multiplied\x20by\x20the\x20International\x20Sensitivity\x20Index\x20(ISI)\x20of\x20the\x20particular\x20thromboplastin\x20reagent.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>Warfarin\x20therapy\x20should\x20be\x20monitored\x20with\x20INR\x20<strong>every\x203&ndash;4\x20weeks</strong>.\x20The\x20<strong>target\x20INR\x20is\x202.0&ndash;3.0</strong>.\x20In\x20patients\x20with\x20<strong>mechanical\x20heart\x20valves</strong>,\x20the\x20target\x20INR\x20is\x20<strong>2.5&ndash;3.5</strong>.</p>','wzxGI','findIndex','stats','UuxfF','(((.+)+)+)+$','video[data-src]','Aminocaproic\x20acid','KoHzN','bookmarkBtn','Gamma\x20glutamyl\x20carboxylase','EJhbe','CYP2C19','JlKid','bookmarked','timeSpent','KmidV','IyjZg','BlLCn','toISOString','FjHqm','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','rhcYU','IAQdj','YigMp','KmPSE','gGYPP','JJJby','qBank','data-option-index','CCHMQ','WcdlX','FyNEy','markedForReview','CLuKV','LqVho','<p>Coagulation\x20profile\x20<strong>monitoring</strong>\x20is\x20needed\x20for\x20<strong>lepirudin</strong>.</p>\x0a<p>Lepirudin\x20is\x20a\x20<strong>direct\x20irreversible\x20thrombin\x20inhibitor</strong>\x20and\x20its\x20most\x20adverse\x20reaction\x20is\x20bleeding.\x20The\x20risk\x20of\x20bleeding\x20can\x20be\x20reduced\x20by\x20implementing\x20an\x20appropriate\x20monitoring\x20and\x20dose\x20adjustment\x20strategy.\x20Thus,\x20coagulation\x20profile\x20monitoring\x20is\x20required\x20for\x20lepirudin.</p>\x0a<p>However,\x20<strong>enoxaparin,\x20fondaparinux,\x20and\x20dabigatran</strong>\x20do\x20not\x20bind\x20to\x20endothelium\x20or\x20many\x20plasma\x20proteins\x20and\x20thus,\x20the\x20response\x20to\x20these\x20drugs\x20at\x20the\x20usual\x20doses\x20is\x20consistent\x20from\x20patient\x20to\x20patient.\x20Hence,\x20monitoring\x20is\x20not\x20required.</p>','SGkpj','DOMContentLoaded','SSmai','OVrPi','length','OIYAP','VEnnW','DpZjT','ZYOKU','wfGnR','nav-btn-answered','Thrombin','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','incorrectAnswers','Bookmark','title','FsPDA','name','azUXD','VeKpd','LZdDY','Prothrombin\x20complex\x20concentrate','isSupported','warn','endsWith','parse','sSuGC','YsrJY','jeTGS','<p>Carbamazepine\x20does\x20not\x20increase\x20the\x20risk\x20of\x20bleeding\x20in\x20patients\x20undergoing\x20warfarin\x20therapy.</p>\x0a<p><strong>Warfarin</strong>&nbsp;is\x20mainly&nbsp;<strong>metabolized&nbsp;</strong>by\x20the<strong>&nbsp;CYP2C9</strong>&nbsp;enzyme.\x20Drugs\x20that\x20inhibit\x20CYP2C9\x20enzyme\x20reduce\x20the\x20metabolism\x20of\x20warfarin\x20and\x20thus,\x20enhance\x20the\x20anticoagulant\x20effect\x20of\x20warfarin\x20and\x20increase\x20the\x20risk\x20of\x20bleeding.</p>\x0a<p>Drugs\x20causing\x20CYP2C9\x20inhibition:</p>\x0a<ul>\x0a<li>Amiodarone</li>\x0a<li>Azole\x20antifungals</li>\x0a<li>Cimetidine</li>\x0a<li>Clopidogrel</li>\x0a<li>Cotrimoxazole</li>\x0a<li>Disulfiram</li>\x0a<li>Isoniazid</li>\x0a<li>Metronidazole</li>\x0a</ul>','rOaUw','getAttribute','<p>The\x20<strong>INR</strong>\x20ratio\x20<strong>recommended</strong>\x20for\x20the\x20administration\x20of\x20warfarin\x20in\x20<strong>most\x20of\x20the\x20indications</strong>\x20is\x20in\x20the\x20range\x20of\x20<strong>2.0-3.0</strong>.</p>\x0a<p>Option\x20A:\x20The\x20range\x20of\x201.0-1.5\x20is\x20too\x20low\x20for\x20beneficial\x20effects.<br\x20/><br\x20/>Option\x20C:\x20In\x20selected\x20patients\x20with\x20<strong>mechanical\x20heart\x20valves</strong>,\x20the\x20INR\x20target\x20is\x20around\x20<strong>2.5-3.5</strong>.</p>\x0a<p>Option\x20D:\x20INR\x20&gt;3.5\x20can\x20result\x20in\x20increased\x20adverse\x20effects\x20and\x20is\x20not\x20recommended\x20for\x20any\x20condition.</p>','modeModal','A\x2050-year-old\x20patient\x20admitted\x20with\x20atrial\x20fibrillation\x20was\x20started\x20on\x20bisoprolol\x20and\x20warfarin.\x20After\x204\x20days\x20of\x20admission,\x20she\x20started\x20experiencing\x20painful\x20ecchymoses\x20on\x20her\x20right\x20lower\x20limb.\x20It\x20progressed\x20to\x20the\x20condition\x20shown\x20in\x20the\x20image\x20over\x20the\x20next\x20few\x20days.\x20Deficiency\x20in\x20which\x20of\x20the\x20following\x20can\x20lead\x20to\x20this\x20condition?','CZvZp','{}.constructor(\x22return\x20this\x22)(\x20)','<p\x20style=\x22text-align:\x20justify;\x22><strong>Factor\x20VII</strong>\x20activity\x20<strong>declines\x20most\x20rapidly</strong>\x20when\x20warfarin\x20is\x20administered.\x20It\x20has\x20the\x20<strong>shortest\x20plasma\x20half-life</strong>\x20among\x20the\x20vitamin\x20K\x20dependent\x20clotting\x20factors.</p>\x0a<table\x20style=\x22width:\x20331px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2017px;\x22>\x0a<td\x20style=\x22height:\x2017px;\x20width:\x20129px;\x22>\x0a<p><strong>Clotting\x20factors</strong></p>\x0a</td>\x0a<td\x20style=\x22height:\x2017px;\x20width:\x20190px;\x22>\x0a<p><strong>Plasma\x20half-life\x20(hours)</strong></p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20129px;\x22>\x0a<p>II</p>\x0a</td>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20190px;\x22>\x0a<p>50</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20129px;\x22>\x0a<p>VII</p>\x0a</td>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20190px;\x22>\x0a<p>6</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20129px;\x22>\x0a<p>IX</p>\x0a</td>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20190px;\x22>\x0a<p>24</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20129px;\x22>\x0a<p>X</p>\x0a</td>\x0a<td\x20style=\x22height:\x2046px;\x20width:\x20190px;\x22>\x0a<p>30</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Clinical\x20importance:\x20Because\x20of\x20the\x20long\x20half-life\x20of\x20the\x20other\x20clotting\x20factors,\x20especially\x20factor\x20II,\x20the\x20<strong>full\x20anticoagulant\x20effect</strong>\x20of\x20warfarin\x20is\x20<strong>not\x20seen\x20for\x20several\x20days</strong>.\x20Initially,\x20parenteral\x20anticoagulants\x20are\x20used\x20along\x20with\x20warfarin\x20until\x20the\x20full\x20effect\x20of\x20warfarin\x20is\x20achieved.</p>','toggle','Dalteparin','mqcJt','jUIZp','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','seFCc','ureBK','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','SESjw','sYqnY','correctResult','Gastroenteritis\x20on\x20treatment\x20with\x20metronidazole','jdeqT','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','location','timed_study','JDwnh','XrfwU','Which\x20of\x20the\x20following\x20is\x20an\x20oral\x20factor\x20Xa\x20inhibitor?','ZDGOv','A\x20patient\x20on\x20anticoagulant\x20therapy\x20presented\x20to\x20the\x20casualty\x20with\x20an\x20uncontrolled\x20bleeding\x20episode\x20and\x20was\x20given\x20IV\x20protamine\x20sulfate.\x20However,\x20the\x20patient\x20did\x20not\x20respond\x20to\x20the\x20treatment.\x20Which\x20of\x20the\x20following\x20anticoagulant\x20agents\x20was\x20most\x20likely\x20being\x20used\x20by\x20the\x20patient?','Parenteral\x20direct\x20thrombin\x20inhibitor','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','text','<p><strong>Andexanet\x20alfa\x20</strong>is\x20the\x20<strong>decoy\x20factor\x20Xa</strong>\x20approved\x20for\x20reversal\x20of\x20oral\x20Xa\x20inhibitors.\x20It\x20was\x20approved\x20in\x20May\x202018.</p>\x0a<p>Option\x20A:\x20Dornase\x20alfa\x20is\x20a\x20recombinant\x20human\x20DNase\x201\x20that\x20is\x20used\x20in\x20cystic\x20fibrosis\x20to\x20reduce\x20the\x20viscosity\x20of\x20mucosal\x20secretions.</p>\x0a<p>Option\x20C:\x20Idarucizumab\x20is\x20a\x20chimeric\x20monoclonal\x20antibody\x20against\x20dabigatran.\x20It\x20has\x20a\x20higher\x20affinity\x20towards\x20dabigatran\x20than\x20thrombin\x20and\x20is\x20approved\x20as\x20a\x20reversal\x20agent\x20for\x20dabigatran.</p>\x0a<p>Option\x20D:\x20Protamine\x20sulfate\x20is\x20an\x20antidote\x20for\x20heparin\x20overdose.</p>','uNREW','PVrau','<p>The\x20<strong>oral\x20thrombin\x20inhibitor</strong>\x20which\x20can\x20be\x20used\x20for\x20the\x20<strong>prevention\x20of\x20stroke</strong>\x20in\x20patients\x20with\x20<strong>non-valvular\x20atrial\x20fibrillation</strong>\x20is\x20<strong>dabigatran</strong>.\x20However,\x20it\x20is\x20contraindicated\x20in\x20patients\x20with\x20mechanical\x20heart\x20valves.</p>\x0a<p>Option\x20B:\x20Ximelagatran\x20is\x20also\x20an\x20oral\x20thrombin\x20inhibitor,\x20but\x20it\x20has\x20been\x20discontinued\x20due\x20to\x20the\x20risk\x20of\x20hepatotoxicity.</p>\x0a<p>Option\x20C:\x20Lepirudin\x20is\x20a\x20parenteral\x20direct\x20thrombin\x20inhibitor\x20used\x20mainly\x20in\x20heparin-induced\x20thrombocytopenia.</p>\x0a<p>Option\x20D:\x20Saxagliptin\x20is\x20a\x20DPP-4\x20inhibitor\x20used\x20in\x20the\x20management\x20of\x20type\x202\x20diabetes\x20mellitus.</p>','scoreCircle','kXIOq','1062UsliXl','MOoDI','vvrZj','WKuWZ','zqwHg','zNjhh','kkcbP'];_0x36c4=function(){return _0x1f4202;};return _0x36c4();}</script>

</body></html>